Nucleic acids that control seed and fruit development in plants

ABSTRACT

The invention provides methods of controlling endosperm development in plants.

FIELD OF THE INVENTION

[0001] The present invention is directed to plant genetic engineering. In particular, it relates to modulation of expression of genes controlling endosperm development in plants.

BACKGROUND OF THE INVENTION

[0002] A fundamental problem in biology is to understand how fertilization initiates reproductive development. In higher plants, the ovule generates the female gametophyte which is composed of egg, central, synergid and antipodal cells (Reiser, et al., Plant Cell, 1291-1301 (1993)). All are haploid except the central cell which contains two daughter nuclei that fuse prior to fertilization. One sperm nucleus fertilizes the egg to form the zygote, whereas another sperm nucleus fuses with the diploid central cell nucleus to form the triploid endosperm nucleus (van Went, et al., Embryology of Angiosperms, pp. 273-318 (1984)). The two fertilization products undergo distinct patterns of development. In Arabidopsis, the embryo passes through a series of stages that have been defined morphologically as preglobular, globular, heart, cotyledon and maturation (Goldberg, R. B., et al., Science (1994) 266: 605-614; Mansfield, S. G., et al., Arabidopsis: An Atlas of Morphology and Development, pp. 367-383 (1994)). The primary endosperm nucleus undergoes a series of mitotic divisions to produce nuclei that migrate into the expanding central cell (Mansfield, S. G., et al., Arab Inf Serv 27: 53-64 (1990); Webb, M. C., et al., Planta 184: 187-195 (1991)). Cytokinesis sequesters endosperm cytoplasm and nuclei into discrete cells (Mansfield, S. G., et al., Arab Inf Serv 27: 65-72 (1990)) that produce storage proteins, starch, and lipids which support embryo growth (Lopes, M. A. et al., Plant Cell 5: 1383-1399 (1993)). Fertilization also activates development of the integument cell layers of the ovule that become the seed coat, and induces the ovary to grow and form the fruit, or silique, in Arabidopsis.

[0003] Control of the expression of genes that control egg and central cell differentiation, or those that activate reproductive development in response to fertilization is useful in the production of plants with a range of desired traits. These and other advantages are provided by the present application.

SUMMARY OF THE INVENTION

[0004] The present invention provides methods of modulating fruit and seed development and other traits in plants. The methods involve providing a plant comprising a recombinant expression cassette containing an FIE nucleic acid linked to a plant promoter.

[0005] In some embodiments, transcription of the FIE nucleic acid inhibits expression of an endogenous FIE gene or activity the encoded protein. This embodiment is particularly useful, for instance, making embryo-less seed and parthenocarpic fruit. Alternatively, expression of the FIE nucleic acid may enhance expression of an endogenous FIE gene or FIE activity

[0006] In the expression cassettes, the plant promoter may be a constitutive promoter, for example, the CaMV 35S promoter. Alternatively, the promoter may be a tissue-specific promoter. Examples of tissue specific expression useful in the invention include ovule-specific or embryo-specific expression. For instance, the promoter sequence from the FIE genes disclosed here can be used to direct expression in relevant plant tissues.

[0007] The invention also provides seed or fruit produced by the methods described above. The seed or fruit of the invention comprise a recombinant expression cassette containing an FIE nucleic acid.

[0008] Definitions

[0009] The phrase “nucleic acid sequence” refers to a single or double-stranded polymer of deoxyribonucleotide or ribonucleotide bases read from the 5′ to the 3′ end. It includes chromosomal DNA, self-replicating plasmids, infectious polymers of DNA or RNA and DNA or RNA that performs a primarily structural role..

[0010] A “promoter” is defined as an array of nucleic acid control sequences that direct transcription of an operably linked nucleic acid. As used herein, a “plant promoter” is a promoter that functions in plants. Promoters include necessary nucleic acid sequences near the start site of transcription, such as, in the case of a polymerase II type promoter, a TATA element. A promoter also optionally includes distal enhancer or repressor elements, which can be located as much as several thousand base pairs from the start site of transcription. A “constitutive” promoter is a promoter that is active under most environmental and developmental conditions. An “inducible” promoter is a promoter that is active under environmental or developmental regulation. The term “operably linked” refers to a functional linkage between a nucleic acid expression control sequence (such as a promoter, or array of transcription factor binding sites) and a second nucleic acid sequence, wherein the expression control sequence directs transcription of the nucleic acid corresponding to the second sequence.

[0011] The term “plant” includes whole plants, plant organs (e.g., leaves, stems, flowers, roots, etc.), seeds and plant cells and progeny of same. The class of plants which can be used in the method of the invention is generally as broad as the class of higher plants amenable to transformation techniques, including angiosperms (monocotyledonous and dicotyledonous plants), as well as gymnosperms. It includes plants of a variety of ploidy levels, including polyploid, diploid, haploid and hemizygous.

[0012] A polynucleotide sequence is “heterologous to” an organism or a second polynucleotide sequence if it originates from a foreign species, or, if from the same species, is modified from its original form. For example, a promoter operably linked to a heterologous coding sequence refers to a coding sequence from a species different from that from which the promoter was derived, or, if from the same species, a coding sequence which is different from any naturally occurring allelic variants.

[0013] A polynucleotide “exogenous to” an individual plant is a polynucleotide which is introduced into the plant by any means other than by a sexual cross. Examples of means by which this can be accomplished are described below, and include Agrobacterium-mediated transformation, biolistic methods, electroporation, and the like. Such a plant containing the exogenous nucleic acid is referred to here as an R₁ generation transgenic plant. Transgenic plants which arise from sexual cross or by selfing are descendants of such a plant.

[0014] A “FIE nucleic acid” or “FIE polynucleotide sequence” of the invention is a subsequence or full length polynucleotide sequence of a gene which encodes a polypeptide involved in control of reproductive development and which, when mutated, allows for aspects of fertilization independent reproductive development. In some embodiments, the polypeptides of the invention have substantial sequence identity (as defined below) to a polycomb group gene of Drosophila. An exemplary nucleic acid of the invention is the Arabidopsis FIE1 and FIE3 sequences disclosed below. FIE polynucleotides are defined by their ability to hybridize under defined conditions to the exemplified nucleic acids or PCR products derived from them. An FIE polynucleotide is typically at least about 30-40 nucleotides to about 3000, usually less than about 5000 nucleotides in length. The nucleic acids contain coding sequence of from about 100 to about 2000 nucleotides, often from about 500 to about 1700 nucleotides in length.

[0015] FIE nucleic acids are a new class of plant regulatory genes that encode polypeptides with sequence identity to members of the polycomb group genes first identified in Drosophila. Polycomb group gene products and their homologues in other species are responsible for repression of homeotic genes. The proteins are a heterogenous group that interact with each other to form large complexes that bind DNA and thereby control gene expression. For a review of the current understanding of polycomb complex genes see, Pirrotta Cur. Op. Genet. Dev. 7:249-258 (1997). Nine groups of polycomb genes have been identified. FIE1 (SEQ ID NO: 1) is related to the group of polycomb genes encoding protein comprising a SET domain (see, e.g., Jenuwein et al. Cell. Mol. Life Sci. 54:80-93 (1998). FIE3 (SEQ ID NO:3) is related to the group encoding proteins comprising WD40 repeats (see, Gutjahr et al. EMBO J. 14:4296-4306 (1995).

[0016] In the case of both expression of transgenes and inhibition of endogenous genes (e.g., by antisense, or sense suppression) one of skill will recognize that the inserted polynucleotide sequence need not be identical, but may be only “substantially identical” to a sequence of the gene from which it was derived. As explained below, these substantially identical variants are specifically covered by the term FIE nucleic acid.

[0017] In the case where the inserted polynucleotide sequence is transcribed and translated to produce a functional polypeptide, one of skill will recognize that because of codon degeneracy a number of polynucleotide sequences will encode the same polypeptide. These variants are specifically covered by the terms “FIE nucleic acid”. In addition, the term specifically includes those sequences substantially identical (determined as described below) with an FIE polynucleotide sequence disclosed here and that encode polypeptides that are either mutants of wild type FIE polypeptides or retain the function of the FIE polypeptide (e.g., resulting from conservative substitutions of amino acids in the FIE polypeptide). In addition, variants can be those that encode dominant negative mutants as described below.

[0018] Two nucleic acid sequences or polypeptides are said to be “identical” if the sequence of nucleotides or amino acid residues, respectively, in the two sequences is the same when aligned for maximum correspondence as described below. The terms “identical” or percent “identity,” in the context of two or more nucleic acids or polypeptide sequences, refer to two or more sequences or subsequences that are the same or have a specified percentage of amino acid residues or nucleotides that are the same, when compared and aligned for maximum correspondence over a comparison window, as measured using one of the following sequence comparison algorithms or by manual alignment and visual inspection. When percentage of sequence identity is used in reference to proteins or peptides, it is recognized that residue positions that are not identical often differ by conservative amino acid substitutions, where amino acids residues are substituted for other amino acid residues with similar chemical properties (e.g., charge or hydrophobicity) and therefore do not change the functional properties of the molecule. Where sequences differ in conservative substitutions, the percent sequence identity may be adjusted upwards to correct for the conservative nature of the substitution. Means for making this adjustment are well known to those of skill in the art. Typically this involves scoring a conservative substitution as a partial rather than a full mismatch, thereby increasing the percentage sequence identity. Thus, for example, where an identical amino acid is given a score of 1 and a non-conservative substitution is given a score of zero, a conservative substitution is given a score between zero and 1. The scoring of conservative substitutions is calculated according to, e.g., the algorithm of Meyers & Miller, Computer Applic. Biol. Sci. 4:11-17 (1988) e.g., as implemented in the program PC/GENE (Intelligenetics, Mountain View, Calif., USA)..

[0019] The phrase “substantially identical,” in the context of two nucleic acids or polypeptides, refers to sequences or subsequences that have at least 60%, preferably 80%, most preferably 90-95% nucleotide or amino acid residue identity when aligned for maximum correspondence over a comparison window as measured using one of the following sequence comparison algorithms or by manual alignment and visual inspection. This definition also refers to the complement of a test sequence, which has substantial sequence or subsequence complementarity when the test sequence has substantial identity to a reference sequence.

[0020] For sequence comparison, typically one sequence acts as a reference sequence, to which test sequences are compared. When using a sequence comparison algorithm, test and reference sequences are entered into a computer, subsequence coordinates are designated, if necessary, and sequence algorithm program parameters are designated. Default program parameters can be used, or alternative parameters can be designated. The sequence comparison algorithm then calculates the percent sequence identities for the test sequences relative to the reference sequence, based on the program parameters.

[0021] A “comparison window”, as used herein, includes reference to a segment of any one of the number of contiguous positions selected from the group consisting of from 20 to 600, usually about 50 to about 200, more usually about 100 to about 150 in which a sequence may be compared to a reference sequence of the same number of contiguous positions after the two sequences are optimally aligned. Methods of alignment of sequences for comparison are well-known in the art. Optimal alignment of sequences for comparison can be conducted, e.g., by the local homology algorithm of Smith & Waterman, Adv. Appl. Math. 2:482 (1981), by the homology alignment algorithm of Needleman & Wunsch, J. Mol. Biol. 48:443 (1970), by the search for similarity method of Pearson & Lipman, Proc. Nat'l. Acad. Sci. USA 85:2444 (1988), by computerized implementations of these algorithms (GAP, BESTFIT, FASTA, and TFASTA in the Wisconsin Genetics Software Package, Genetics Computer Group, 575 Science Dr., Madison, Wis.), or by manual alignment and visual inspection.

[0022] One example of a useful algorithm is PILEUP. PILEUP creates a multiple sequence alignment from a group of related sequences using progressive, pairwise alignments to show relationship and percent sequence identity. It also plots a tree or dendogram showing the clustering relationships used to create the alignment. PILEUP uses a simplification of the progressive alignment method of Feng & Doolittle, J. Mol. Evol. 35:351-360 (1987). The method used is similar to the method described by Higgins & Sharp, CABIOS 5:151-153 (1989). The program can align up to 300 sequences, each of a maximum length of 5,000 nucleotides or amino acids. The multiple alignment procedure begins with the pairwise alignment of the two most similar sequences, producing a cluster of two aligned sequences. This cluster is then aligned to the next most related sequence or cluster of aligned sequences. Two clusters of sequences are aligned by a simple extension of the pairwise alignment of two individual sequences. The final alignment is achieved by a series of progressive, pairwise alignments. The program is run by designating specific sequences and their amino acid or nucleotide coordinates for regions of sequence comparison and by designating the program parameters. For example, a reference sequence can be compared to other test sequences to determine the percent sequence identity relationship using the following parameters: default gap weight (3.00), default gap length weight (0.10), and weighted end gaps.

[0023] Another example of algorithm that is suitable for determining percent sequence identity and sequence similarity is the BLAST algorithm, which is described in Altschul et al., J. Mol. Biol. 215:403-410 (1990). Software for performing BLAST analyses is publicly available through the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/). This algorithm involves first identifying high scoring sequence pairs (HSPs) by identifying short words of length W in the query sequence, which either match or satisfy some positive-valued threshold score T when aligned with a word of the same length in a database sequence. T is referred to as the neighborhood word score threshold (Altschul et al, supra). These initial neighborhood word hits act as seeds for initiating searches to find longer HSPs containing them. The word hits are extended in both directions along each sequence for as far as the cumulative alignment score can be increased. Extension of the word hits in each direction are halted when: the cumulative alignment score falls off by the quantity X from its maximum achieved value; the cumulative score goes to zero or below, due to the accumulation of one or more negative-scoring residue alignments; or the end of either sequence is reached. The BLAST algorithm parameters W, T, and X determine the sensitivity and speed of the alignment. The BLAST program uses as defaults a wordlength (W) of 11, the BLOSUM62 scoring matrix (see Henikoff & Henikoff, Proc. Natl. Acad. Sci. USA 89:10915 (1989)) alignments (B) of 50, expectation (E) of 10, M=5, N=−4, and a comparison of both strands.

[0024] The BLAST algorithm also performs a statistical analysis of the similarity between two sequences (see, e.g., Karlin & Altschul, Proc. Nat'l. Acad. Sci. USA 90:5873-5787 (1993)). One measure of similarity provided by the BLAST algorithm is the smallest sum probability (P(N)), which provides an indication of the probability by which a match between two nucleotide or amino acid sequences would occur by chance. For example, a nucleic acid is considered similar to a reference sequence if the smallest sum probability in a comparison of the test nucleic acid to the reference nucleic acid is less than about 0.2, more preferably less than about 0.01, and most preferably less than about 0.001.

[0025] “Conservatively modified variants” applies to both amino acid and nucleic acid sequences. With respect to particular nucleic acid sequences, conservatively modified variants refers to those nucleic acids which encode identical or essentially identical amino acid sequences, or where the nucleic acid does not encode an amino acid sequence, to essentially identical sequences. Because of the degeneracy of the genetic code, a large number of functionally identical nucleic acids encode any given protein. For instance, the codons GCA, GCC, GCG and GCU all encode the amino acid alanine. Thus, at every position where an alanine is specified by a codon, the codon can be altered to any of the corresponding codons described without altering the encoded polypeptide. Such nucleic acid variations are “silent variations,” which are one species of conservatively modified variations. Every nucleic acid sequence herein which encodes a polypeptide also describes every possible silent variation of the nucleic acid. One of skill will recognize that each codon in a nucleic acid (except AUG, which is ordinarily the only codon for methionine) can be modified to yield a functionally identical molecule. Accordingly, each silent variation of a nucleic acid which encodes a polypeptide is implicit in each described sequence.

[0026] As to amino acid sequences, one of skill will recognize that individual substitutions, deletions or additions to a nucleic acid, peptide, polypeptide, or protein sequence which alters, adds or deletes a single amino acid or a small percentage of amino acids in the encoded sequence is a “conservatively modified variant” where the alteration results in the substitution of an amino acid with a chemically similar amino acid. Conservative substitution tables providing functionally similar amino acids are well known in the art.

[0027] The following six groups each contain amino acids that are conservative substitutions for one another:

[0028] 1) Alanine (A), Serine (S), Threonine (T);

[0029] 2) Aspartic acid (D), Glutamic acid (E);

[0030] 3) Asparagine (N), Glutamine (Q);

[0031] 4) Arginine (R), Lysine (K);

[0032] 5) Isoleucine (I), Leucine (L), Methionine (M), Valine (V); and

[0033] 6) Phenylalanine (F), Tyrosine (Y), Tryptophan (W). (see, e.g., Creighton, Proteins (1984)).

[0034] An indication that two nucleic acid sequences or polypeptides are substantially identical is that the polypeptide encoded by the first nucleic acid is immunologically cross reactive with the antibodies raised against the polypeptide encoded by the second nucleic acid. Thus, a polypeptide is typically substantially identical to a second polypeptide, for example, where the two peptides differ only by conservative substitutions. Another indication that two nucleic acid sequences are substantially identical is that the two molecules or their complements hybridize to each other under stringent conditions, as described below.

[0035] The phrase “selectively (or specifically) hybridizes to” refers to the binding, duplexing, or hybridizing of a molecule only to a particular nucleotide sequence under stringent hybridization conditions when that sequence is present in a complex mixture (e.g., total cellular or library DNA or RNA).

[0036] The phrase “stringent hybridization conditions” refers to conditions under which a probe will hybridize to its target subsequence, typically in a complex mixture of nucleic acid, but to no other sequences. Stringent conditions are sequence-dependent and will be different in different circumstances. Longer sequences hybridize specifically at higher temperatures. An extensive guide to the hybridization of nucleic acids is found in Tijssen, Techniques in Biochemistry and Molecular Biology-Hybridization with Nucleic Probes, “Overview of principles of hybridization and the strategy of nucleic acid assays” (1993). Generally, highly stringent conditions are selected to be about 5-10° C. lower than the thermal melting point (T_(m)) for the specific sequence at a defined ionic strength pH. Low stringency conditions are generally selected to be about 15-30° C. below the T_(m). The T_(m) is the temperature (under defined ionic strength, pH, and nucleic concentration) at which 50% of the probes complementary to the target hybridize to the target sequence at equilibrium (as the target sequences are present in excess, at T_(m), 50% of the probes are occupied at equilibrium). Stringent conditions will be those in which the salt concentration is less than about 1.0M sodium ion, typically about 0.01 to 1.0M sodium ion concentration (or other salts) at pH 7.0 to 8.3 and the temperature is at least about 30° C. for short probes (e.g., 10 to 50 nucleotides) and at least about 60° C. for long probes (e.g., greater than 50 nucleotides). Stringent conditions may also be achieved with the addition of destabilizing agents such as formamide. For selective or specific hybridization, a positive signal is at least two times background, preferably 10 time background hybridization.

[0037] Nucleic acids that do not hybridize to each other under stringent conditions are still substantially identical if the polypeptides which they encode are substantially identical. This occurs, for example, when a copy of a nucleic acid is created using the maximum codon degeneracy permitted by the genetic code. In such cased, the nucleic acids typically hybridize under moderately stringent hybridization conditions.

[0038] In the present invention, genomic DNA or cDNA comprising FIE nucleic acids of the invention can be identified in standard Southern blots under stringent conditions using the nucleic acid sequences disclosed here. For the purposes of this disclosure, suitable stringent conditions for such hybridizations are those which include a hybridization in a buffer of 40% formamide, 1M NaCl, 1% SDS at 37° C., and at least one wash in 0.2× SSC at a temperature of at least about 50° C., usually about 55° C. to about 60° C., for 20 minutes, or equivalent conditions. A positive hybridization is at least twice background. Those of ordinary skill will readily recognize that alternative hybridization and wash conditions can be utilized to provide conditions of similar stringency.

[0039] A further indication that two polynucleotides are substantially identical is if the reference sequence, amplified by a pair of oligonucleotide primers, can then be used as a probe under stringent hybridization conditions to isolate the test sequence from a cDNA or genomic library, or to identify the test sequence in, e.g., a northern or Southern blot.

BRIEF DESCRIPTION OF THE DRAWINGS

[0040]FIGS. 1A and 1B show the genetic map used to clone the FIE3 gene.

[0041]FIG. 2 shows the analysis of the sequence in the DNA shown in FIG. 1 using the GENSCANW program.

[0042]FIG. 3 shows the position of primers used to PCR amplify sequences from the FIE3 gene region.

[0043]FIG. 4 shows the genetic map used to clone the FIE1 gene.

[0044]FIG. 5 shows the results of complementation tests establishing that a single gene (FIE1) was present on the complementing cosmid (6-22) that was not fully encoded on either of the non-complementing cosmids (2-9 and 2-8).

DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0045] This invention provides molecular strategies for controlling seed and fruit development.

[0046] Reproduction in higher plants is unique because it is initiated by two fertilization events in the haploid female gametophyte. One sperm nucleus fertilizes the egg to form the embryo. A second sperm nucleus fertilizes the central cell to form the endosperm, a unique tissue that supports the growth of the embryo. Fertilization also activates maternal tissue differentiation, the ovule integuments form the seed coat and the ovary forms the fruit.

[0047] The present invention is based, at least in part, on the discovery of a set of female-gametophytic mutations, termed fie (fertilization-independent endosperm), and the subsequent cloning of the genes involved. Three mutants are disclosed here fie1, fie2, and fie3, which have been mapped to chromosomes 1, 2, and 3 of Arabidopsis, respectively. The fie mutations affect the central cell, allowing for replication of the central cell nucleus and endosperm development without fertilization. FIE/fie seed coat and fruit undergo fertilization-independent differentiation, showing that the fie female gametophyte is the source of signals that activates sporophytic fruit and seed coat development. Generally, the mutant fie alleles are not transmitted by the female gametophyte. Inheritance of a mutant fie allele (e.g., fie3) by the female gametophyte usually results in embryo abortion, even when the pollen bears the wild-type FIE allele. In the case of fie1 and fie2, however, transmission of the trait occurs in about 1% of the progeny from the female gametophyte. In contrast, the fie1, fie2, and fie3 mutant alleles are passed through the male gametophyte (i.e., pollen) in normal fashion.

[0048] The isolated sequences prepared as described herein, can be used in a number of techniques, for example, to suppress or enhance endogenous FIE gene expression. Modulation of FIE gene expression or FIE activity in plants is particularly useful, for example, in producing embryo-less seed, parthenocarpic fruit, or as part of a system to generate apomictic seed.

[0049] Isolation of FIE nucleic acids

[0050] Generally, the nomenclature and the laboratory procedures in recombinant DNA technology described below are those well known and commonly employed in the art. Standard techniques are used for cloning, DNA and RNA isolation, amplification and purification. Generally enzymatic reactions involving DNA ligase, DNA polymerase, restriction endonucleases and the like are performed according to the manufacturer's specifications. These techniques and various other techniques are generally performed according to Sambrook et al., Molecular Cloning-A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y., (1989).

[0051] The isolation of FIE nucleic acids may be accomplished by a number of techniques. For instance, oligonucleotide probes based on the sequences disclosed here can be used to identify the desired gene in a cDNA or genomic DNA library. To construct genomic libraries, large segments of genomic DNA are generated by random fragmentation, e.g. using restriction endonucleases, and are ligated with vector DNA to form concatemers that can be packaged into the appropriate vector. To prepare a cDNA library, mRNA is isolated from the desired organ, such as ovules, and a cDNA library which contains the FIE gene transcript is prepared from the mRNA. Alternatively, cDNA may be prepared from mRNA extracted from other tissues in which FIE genes or homologs are expressed.

[0052] The cDNA or genomic library can then be screened using a probe based upon the sequence of a cloned FIE gene disclosed here. Probes may be used to hybridize with genomic DNA or cDNA sequences to isolate homologous genes in the same or different plant species. Alternatively, antibodies raised against an FIE polypeptide can be used to screen an mRNA expression library.

[0053] Alternatively, the nucleic acids of interest can be amplified from nucleic acid samples using amplification techniques. For instance, polymerase chain reaction (PCR) technology can be used to amplify the sequences of the FIE genes directly from genomic DNA, from cDNA, from genomic libraries or cDNA libraries. PCR and other in vitro amplification methods may also be useful, for example, to clone nucleic acid sequences that code for proteins to be expressed, to make nucleic acids to use as probes for detecting the presence of the desired mRNA in samples, for nucleic acid sequencing, or for other purposes. For a general overview of PCR see PCR Protocols: A Guide to Methods and Applications. (Innis, M, Gelfand, D., Sninsky, J. and White, T., eds.), Academic Press, San Diego (1990).

[0054] Appropriate primers and probes for identifying FIE sequences from plant tissues are generated from comparisons of the sequences provided here with other polycomb group genes. For instance, FIE1 can be compared to the other polycomb genes containing the SET domain, such as the Arabidopsis curly leaf gene (Goodrich et al. Nature 386:44-51 (1997)) or the Drosophila enhancer of zeste (E(z)) gene. FIE3 can be compared to genes containing WD40 repeats, such as the extra sex combs (esc) gene from Drosophila. Using these techniques, one of skill can identify conserved regions in the nucleic acids disclosed here to prepare the appropriate primer and probe sequences. Primers that specifically hybridize to conserved regions in FIE1 or FIE3 genes can be used to amplify sequences from widely divergent plant species.

[0055] Standard nucleic acid hybridization techniques using the conditions disclosed above can then be used to identify full length cDNA or genomic clones.

[0056] Control of FIE activity or gene expression

[0057] Since FIE genes are involved in controlling seed, in particular endosperm, development, inhibition of endogenous Fie activity or gene expression is useful in a number of contexts. For instance, inhibition of expression is useful in the development of parthenocarpic fruit (i.e., fruit formed in the absence of fertilization).

[0058] In addition, inhibition of FIE activity can be used for production of fruit with small and/or degraded seed (referred to here as “seedless fruit”) after fertilization. In many plants, particularly dicots, the endosperm is not persistent and eventually is degraded. Thus, in plants of the invention in which Fie activity is inhibited, embryo-less seed do not persist and seedless fruit are produced.

[0059] Alternatively, plants of the invention can be used to prevent pre-harvest sprouting in seeds, especially those derived from cereals. In these plants, the endosperm persists and is the major component of the mature seed. Premature growth of embryos in stored grain causes release of degradative enzymes which digest starch and other components of the endosperm. Plants of the present invention are useful in addressing this problem because the seeds lack an embryo and thus will not germinate.

[0060] In yet another use, nucleic acids of the invention can be used in the development of apomictic plant lines (i.e., plants in which asexual reproductive processes occur in the ovule, see, Koltunow, A. Plant Cell 5: 1425-1437 (1993) for a discussion of apomixis). Apomixis provides a novel means to select and fix complex heterozygous genotypes that cannot be easily maintained by traditional breeding. Thus, for instance, new hybrid lines with desired traits (e.g., hybrid vigor) can be obtained and readily maintained.

[0061] One of skill will recognize that a number of methods can be used to modulate FIE activity or gene expression. FIE activity can be modulated in the plant cell at the gene, transcriptional, posttranscriptional, translational, or posttranslational, levels. Techniques for modulating FIE activity at each of these levels are generally well known to one of skill and are discussed briefly below.

[0062] Methods for introducing genetic mutations into plant genes are well known. For instance, seeds or other plant material can be treated with a mutagenic chemical substance, according to standard techniques. Such chemical substances include, but are not limited to, the following: diethyl sulfate, ethylene imine, ethyl methanesulfonate and N-nitroso-N-ethylurea. Alternatively, ionizing radiation from sources such as, for example, X-rays or gamma rays can be used.

[0063] Alternatively, homologous recombination can be used to induce targeted gene disruptions by specifically deleting or altering the FIE gene in vivo (see, generally, Grewal and Klar, Genetics 146: 1221-1238 (1997) and Xu et al., Genes Dev. 10: 2411-2422 (1996)). Homologous recombination has been demonstrated in plants (Puchta et al., Experientia 50: 277-284 (1994), Swoboda et al., EMBO J. 13: 484-489 (1994); Offringa et al., Proc. Natl. Acad. Sci. USA 90: 7346-7350 (1993); and Kempin et al. Nature 389:802-803 (1997)).

[0064] In applying homologous recombination technology to the genes of the invention, mutations in selected portions of an FIE gene sequences (including 5′ upstream, 3′ downstream, and intragenic regions) such as those disclosed here are made in vitro and then introduced into the desired plant using standard techniques. Since the efficiency of homologous recombination is known to be dependent on the vectors used, use of dicistronic gene targeting vectors as described by Mountford et al. Proc. Natl. Acad. Sci. USA 91: 4303-4307 (1994); and Vaulont et al. Transgenic Res. 4: 247-255 (1995) are conveniently used to increase the efficiency of selecting for altered FIE gene expression in transgenic plants. The mutated gene will interact with the target wild-type gene in such a way that homologous recombination and targeted replacement of the wild-type gene will occur in transgenic plant cells, resulting in suppression of FIE activity.

[0065] Alternatively, oligonucleotides composed of a contiguous stretch of RNA and DNA residues in a duplex conformation with double hairpin caps on the ends can be used. The RNA/DNA sequence is designed to align with the sequence of the target FIE gene and to contain the desired nucleotide change. Introduction of the chimeric oligonucleotide on an extrachromosomal T-DNA plasmid results in efficient and specific FIE gene conversion directed by chimeric molecules in a small number of transformed plant cells. This method is described in Cole-Strauss et al. Science 273:1386-1389 (1996) and Yoon et al. Proc. Natl. Acad. Sci. USA 93: 2071-2076 (1996).

[0066] Gene expression can be inactivated using recombinant DNA techniques by transforming plant cells with constructs comprising transposons or T-DNA sequences. FIE mutants prepared by these methods are identified according to standard techniques. For instance, mutants can be detected by PCR or by detecting the presence or absence of FIE mRNA, e.g., by Northern blots. Mutants can also be selected by assaying for development of endosperm in the absence of fertilization.

[0067] The isolated nucleic acid sequences prepared as described herein, can also be used in a number of techniques to control endogenous FIE gene expression at various levels. Subsequences from the sequences disclosed here can be used to control, transcription, RNA accumulation, translation, and the like.

[0068] A number of methods can be used to inhibit gene expression in plants. For instance, antisense technology can be conveniently used. To accomplish this, a nucleic acid segment from the desired gene is cloned and operably linked to a promoter such that the antisense strand of RNA will be transcribed. The construct is then transformed into plants and the antisense strand of RNA is produced. In plant cells, it has been suggested that antisense suppression can act at all levels of gene regulation including suppression of RNA translation (see, Bourque Plant Sci. (Limerick) 105: 125-149 (1995); Pantopoulos In Progress in Nucleic Acid Research and Molecular Biology, Vol. 48. Cohn, W. E. and K. Moldave (Ed.). Academic Press, Inc.: San Diego, Calif., USA; London, England, UK. p. 181-238; Heiser et al. Plant Sci. (Shannon) 127: 61-69 (1997)) and by preventing the accumulation of mRNA which encodes the protein of interest, (see, Baulcombe Plant Mol. Bio. 32:79-88 (1996); Prins and Goldbach Arch. Virol. 141: 2259-2276 (1996); Metzlaff et al. Cell 88: 845-854 (1997), Sheehy et al., Proc. Nat. Acad. Sci. USA, 85:8805-8809 (1988), and Hiatt et al., U.S. Pat. No. 4,801,340).

[0069] The nucleic acid segment to be introduced generally will be substantially identical to at least a portion of the endogenous FIE gene or genes to be repressed. The sequence, however, need not be perfectly identical to inhibit expression. The vectors of the present invention can be designed such that the inhibitory effect applies to other genes within a family of genes exhibiting homology or substantial homology to the target gene.

[0070] For antisense suppression, the introduced sequence also need not be full length relative to either the primary transcription product or fully processed mRNA. Generally, higher homology can be used to compensate for the use of a shorter sequence. Furthermore, the introduced sequence need not have the same intron or exon pattern, and homology of non-coding segments may be equally effective. Normally, a sequence of between about 30 or 40 nucleotides and about full length nucleotides should be used, though a sequence of at least about 100 nucleotides is preferred, a sequence of at least about 200 nucleotides is more preferred, and a sequence of about 500 to about 1700 nucleotides is especially preferred.

[0071] A number of gene regions can be targeted to suppress FIE gene expression. The targets can include, for instance, the coding regions, introns, sequences from exon/intron junctions, 5′ or 3′ untranslated regions, and the like. In some embodiments, the constructs can be designed to eliminate the ability of regulatory proteins to bind to FIE gene sequences that are required for its cell- and/or tissue-specific expression. Such transcriptional regulatory sequences can be located either 5′-, 3′-, or within the coding region of the gene and can be either promote (positive regulatory element) or repress (negative regulatory element) gene transcription. These sequences can be identified using standard deletion analysis, well known to those of skill in the art. Once the sequences are identified, an antisense construct targeting these sequences is introduced into plants to control gene transcription in particular tissue, for instance, in developing ovules and/or seed.

[0072] Oligonucleotide-based triple-helix formation can be used to disrupt FIE gene expression. Triplex DNA can inhibit DNA transcription and replication, generate site-specific mutations, cleave DNA, and induce homologous recombination (see, e.g., Havre and Glazer J. Virology 67:7324-7331 (1993); Scanlon et al. FASEB J. 9:1288-1296 (1995); Giovannangeli et al. Biochemistry 35:10539-10548 (1996); Chan and Glazer J. Mol. Medicine (Berlin) 75: 267-282 (1997)). Triple helix DNAs can be used to target the same sequences identified for antisense regulation.

[0073] Catalytic RNA molecules or ribozymes can also be used to inhibit expression of FIE genes. It is possible to design ribozymes that specifically pair with virtually any target RNA and cleave the phosphodiester backbone at a specific location, thereby functionally inactivating the target RNA. In carrying out this cleavage, the ribozyme is not itself altered, and is thus capable of recycling and cleaving other molecules, making it a true enzyme. The inclusion of ribozyme sequences within antisense RNAs confers RNA-cleaving activity upon them, thereby increasing the activity of the constructs. Thus, ribozymes can be used to target the same sequences identified for antisense regulation.

[0074] A number of classes of ribozymes have been identified. One class of ribozymes is derived from a number of small circular RNAs which are capable of self-cleavage and replication in plants. The RNAs replicate either alone (viroid RNAs) or with a helper virus (satellite RNAs). Examples include RNAs from avocado sunblotch viroid and the satellite RNAs from tobacco ringspot virus, lucerne transient streak virus, velvet tobacco mottle virus, solanum nodiflorum mottle virus and subterranean clover mottle virus. The design and use of target RNA-specific ribozymes is described in Zhao and Pick Nature 365:448-451 (1993); Eastham and Ahlering J. Urology 156:1186-1188 (1996); Sokol and Murray Transgenic Res. 5:363-371 (1996); Sun et al. Mol. Biotechnology 7:241-251 (1997); and Haseloff et al. Nature, 334:585-591 (1988).

[0075] Another method of suppression is sense cosuppression. Introduction of nucleic acid configured in the sense orientation has been recently shown to be an effective means by which to block the transcription of target genes. For an example of the use of this method to modulate expression of endogenous genes (see, Assaad et al. Plant Mol. Bio. 22: 1067-1085 (1993); Flavell Proc. Natl. Acad. Sci. USA 91: 3490-3496 (1994); Stain et al. Annals Bot. 79: 3-12 (1997); Napoli et al., The Plant Cell 2:279-289 (1990); and U.S. Pat. Nos. 5,034,323, 5,231,020, and 5,283,184).

[0076] The suppressive effect may occur where the introduced sequence contains no coding sequence per se, but only intron or untranslated sequences homologous to sequences present in the primary transcript of the endogenous sequence. The introduced sequence generally will be substantially identical to the endogenous sequence intended to be repressed. This minimal identity will typically be greater than about 65%, but a higher identity might exert a more effective repression of expression of the endogenous sequences. Substantially greater identity of more than about 80% is preferred, though about 95% to absolute identity would be most preferred. As with antisense regulation, the effect should apply to any other proteins within a similar family of genes exhibiting homology or substantial homology.

[0077] For sense suppression, the introduced sequence, needing less than absolute identity, also need not be full length, relative to either the primary transcription product or fully processed mRNA. This may be preferred to avoid concurrent production of some plants which are overexpressers. A higher identity in a shorter than full length sequence compensates for a longer, less identical sequence. Furthermore, the introduced sequence need not have the same intron or exon pattern, and identity of non-coding segments will be equally effective. Normally, a sequence of the size ranges noted above for antisense regulation is used. In addition, the same gene regions noted for antisense regulation can be targetted using cosuppression technologies.

[0078] Alternatively, FIE activity may be modulated by eliminating the proteins that are required for FIE cell-specific gene expression. Thus, expression of regulatory proteins and/or the sequences that control FIE gene expression can be modulated using the methods described here.

[0079] Another method is use of engineered tRNA suppression of FIE mRNA translation. This method involves the use of suppressor tRNAs to transactivate target genes containing premature stop codons (see, Betzner et al. Plant J. 11:587-595 (1997); and Choisne et al. Plant J. 11: 597-604 (1997). A plant line containing a constitutively expressed FIE gene that contains an amber stop codon is first created. Multiple lines of plants, each containing tRNA suppressor gene constructs under the direction of cell-type specific promoters are also generated. The tRNA gene construct is then crossed into the FIE line to activate FIE activity in a targeted manner. These tRNA suppressor lines could also be used to target the expression of any type of gene to the same cell or tissue types.

[0080] As noted above, FIE proteins as products of polycomb group genes are believed to form large complexes in vivo. Thus, production of dominant-negative forms of FIE polypeptides that are defective in their abilities to bind to other polycomb group proteins is a convenient means to inhibit endogenous FIE activity. This approach involves transformation of plants with constructs encoding mutant FIE polypeptides that form defective complexes with endogenous polycomb group proteins and thereby prevent the complex from forming properly. The mutant polypeptide may vary from the naturally occurring sequence at the primary structure level by amino acid substitutions, additions, deletions, and the like. These modifications can be used in a number of combinations to produce the final modified protein chain. Use of dominant negative mutants to inactivate target genes is described in Mizukami et al. Plant Cell 8:831-845 (1996).

[0081] Another strategy to affect the ability of an FIE protein to interact with itself or with other proteins involves the use of antibodies specific to FIE. In this method cell-specific expression of FIE-specific Abs is used inactivate functional domains through antibody:antigen recognition (see, Hupp et al. Cell 83:237-245 (1995)).

[0082] Use of nucleic acids of the invention to enhance FIE gene expression

[0083] Isolated sequences prepared as described herein can also be used to introduce expression of a particular FIE nucleic acid to enhance or increase endogenous gene expression. For instance, polycomb genes are known to control cell cycling. Enhanced expression can therefore be used to control plant morphology by controlling whether or not cell division takes place in desired tissues or cells. Enhanced expression can also be used, for instance, to increase vegetative growth by preventing the plant from setting seed. Where overexpression of a gene is desired, the desired gene from a different species may be used to decrease potential sense suppression effects.

[0084] One of skill will recognize that the polypeptides encoded by the genes of the invention, like other proteins, have different domains which perform different functions. Thus, the gene sequences need not be full length, so long as the desired functional domain of the protein is expressed.

[0085] Modified protein chains can also be readily designed utilizing various recombinant DNA techniques well known to those skilled in the art and described in detail, below. For example, the chains can vary from the naturally occurring sequence at the primary structure level by amino acid substitutions, additions, deletions, and the like. These modifications can be used in a number of combinations to produce the final modified protein chain.

[0086] Preparation of recombinant vectors

[0087] To use isolated sequences in the above techniques, recombinant DNA vectors suitable for transformation of plant cells are prepared. Techniques for transforming a wide variety of higher plant species are well known and described in the technical and scientific literature. See, for example, Weising et al. Ann. Rev. Genet. 22:421-477 (1988). A DNA sequence coding for the desired polypeptide, for example a cDNA sequence encoding a full length protein, will preferably be combined with transcriptional and translational initiation regulatory sequences which will direct the transcription of the sequence from the gene in the intended tissues of the transformed plant.

[0088] For example, for overexpression, a plant promoter fragment may be employed which will direct expression of the gene in all tissues of a regenerated plant. Such promoters are referred to herein as “constitutive” promoters and are active under most environmental conditions and states of development or cell differentiation. Examples of constitutive promoters include the cauliflower mosaic virus (CaMV) 35S transcription initiation region, the 1′- or 2′- promoter derived from T-DNA of Agrobacterium tumafaciens, and other transcription initiation regions from various plant genes known to those of skill. Such genes include for example, ACT11 from Arabidopsis (Huang et al. Plant Mol. Biol. 33:125-139 (1996)), Cat3 from Arabidopsis (GenBank No. U43147, Zhong et al., Mol. Gen. Genet. 251:196-203 (1996)), the gene encoding stearoyl-acyl carrier protein desaturase from Brassica napus (Genbank No. X74782, Solocombe et al. Plant Physiol. 104:1167-1176 (1994)), GPc1 from maize (GenBank No. X15596, Martinez et al. J. Mol. Biol 208:551-565 (1989)), and Gpc2 from maize (GenBank No. U45855, Manjunath et al., Plant Mol. Biol. 33:97-112 (1997)).

[0089] Alternatively, the plant promoter may direct expression of the FIE nucleic acid in a specific tissue or may be otherwise under more precise environmental or developmental control. Examples of environmental conditions that may effect transcription by inducible promoters include anaerobic conditions, elevated temperature, or the presence of light. Such promoters are referred to here as “inducible” or “tissue-specific” promoters. One of skill will recognize that a tissue-specific promoter may drive expression of operably linked sequences in tissues other than the target tissue. Thus, as used herein a tissue-specific promoter is one that drives expression preferentially in the target tissue, but may also lead to some expression in other tissues as well.

[0090] Examples of promoters under developmental control include promoters that initiate transcription only (or primarily only) in certain tissues, such as fruit, seeds, or flowers. Promoters that direct expression of nucleic acids in ovules, flowers or seeds are particularly useful in the present invention. As used herein a seed-specific promoter is one which directs expression in seed tissues, such promoters may be, for example, ovule-specific (which includes promoters which direct expression in maternal tissues or the female gametophyte, such as egg cells or the central cell), embryo-specific, endosperm-specific, integument-specific, seed coat-specific, or some combination thereof. Examples include a promoter from the ovule-specific BEL1 gene described in Reiser et al. Cell 83:735-742 (1995) (GenBank No. U39944). Other suitable seed specific promoters are derived from the following genes: MAC1 from maize (Sheridan et al. Genetics 142:1009-1020 (1996), Cat3 from maize (GenBank No. L05934, Abler et al. Plant Mol. Biol. 22:10131-1038 (1993), the gene encoding oleosin 18kD from maize (GenBank No. J05212, Lee et al. Plant Mol. Biol. 26:1981-1987 (1994)), vivparous-1 from Arabidopsis (Genbank No. U93215), the gene encoding oleosin from Arabidopsis (Genbank No. Z17657), Atmyc1 from Arabidopsis (Urao et al. Plant Mol. Biol. 32:571-576 (1996), the 2s seed storage protein gene family from Arabidopsis (Conceicao et al. Plant 5:493-505 (1994)) the gene encoding oleosin 20kD from Brassica napus (GenBank No. M63985), napA from Brassica napus (GenBank No. J02798, Josefsson et al. JBL 26:12196-1301 (1987), the napin gene family from Brassica napus (Sjodahl et al. Planta 197:264-271 (1995), the gene encoding the 2S storage protein from Brassica napus (Dasgupta et al. Gene 133:301-302 (1993)), the genes encoding oleosin A (Genbank No. U09118) and oleosin B (Genbank No. U09119) from soybean and the gene encoding low molecular weight sulphur rich protein from soybean (Choi et al. Mol Gen, Genet. 246:266-268 (1995)).

[0091] In addition, the promoter sequences from the FIE genes disclosed here can be used to drive expression of the FIE polynucleotides of the invention or heterologous sequences. The sequences of the promoters are identified below.

[0092] If proper polypeptide expression is desired, a polyadenylation region at the 3′-end of the coding region should be included. The polyadenylation region can be derived from the natural gene, from a variety of other plant genes, or from T-DNA.

[0093] The vector comprising the sequences (e.g., promoters or coding regions) from genes of the invention will typically comprise a marker gene which confers a selectable phenotype on plant cells. For example, the marker may encode biocide resistance, particularly antibiotic resistance, such as resistance to kanamycin, G418, bleomycin, hygromycin, or herbicide resistance, such as resistance to chlorosulfuron or Basta.

[0094] Production of transgenic plants

[0095] DNA constructs of the invention may be introduced into the genome of the desired plant host by a variety of conventional techniques. For example, the DNA construct may be introduced directly into the genomic DNA of the plant cell using techniques such as electroporation and microinjection of plant cell protoplasts, or the DNA constructs can be introduced directly to plant tissue using ballistic methods, such as DNA particle bombardment.

[0096] Microinjection techniques are known in the art and well described in the scientific and patent literature. The introduction of DNA constructs using polyethylene glycol precipitation is described in Paszkowski et al. Embo J. 3:2717-2722 (1984). Electroporation techniques are described in Fromm et al. Proc. Natl. Acad. Sci. USA 82:5824 (1985). Ballistic transformation techniques are described in Klein et al. Nature 327:70-73 (1987).

[0097] Alternatively, the DNA constructs may be combined with suitable T-DNA flanking regions and introduced into a conventional Agrobacterium tumefaciens host vector. The virulence functions of the Agrobacterium tumefaciens host will direct the insertion of the construct and adjacent marker into the plant cell DNA when the cell is infected by the bacteria. Agrobacterium tumefaciens-mediated transformation techniques, including disarming and use of binary vectors, are well described in the scientific literature. See, for example Horsch et al. Science 233:496-498 (1984), and Fraley et al. Proc. Natl. Acad. Sci. USA 80:4803 (1983).

[0098] Transformed plant cells which are derived by any of the above transformation techniques can be cultured to regenerate a whole plant which possesses the transformed genotype and thus the desired phenotype such as increased seed mass. Such regeneration techniques rely on manipulation of certain phytohormones in a tissue culture growth medium, typically relying on a biocide and/or herbicide marker which has been introduced together with the desired nucleotide sequences. Plant regeneration from cultured protoplasts is described in Evans et al., Protoplasts Isolation and Culture, Handbook of Plant Cell Culture, pp. 124-176, MacMillilan Publishing Company, New York, 1983; and Binding, Regeneration of Plants, Plant Protoplasts, pp. 21-73, CRC Press, Boca Raton, 1985. Regeneration can also be obtained from plant callus, explants, organs, or parts thereof. Such regeneration techniques are described generally in Klee et al. Ann. Rev. of Plant Phys. 38:467-486 (1987).

[0099] The nucleic acids of the invention can be used to confer desired traits on essentially any plant. Thus, the invention has use over a broad range of plants, including species from the genera Anacardium, Arachis, Asparagus, Atropa, Avena, Brassica, Citrus, Citrullus, Capsicum, Carthamus, Cocos, Coffea, Cucumis, Cucurbita, Daucus, Elaeis, Fragaria, Glycine, Gossypium, Helianthus, Heterocallis, Hordeum, Hyoscyamus, Lactuca, Linum, Lolium, Lupinus, Lycopersicon, Malus, Manihot, Majorana, Medicago, Nicotiana, Olea, Oryza, Panieum, Pannesetum, Persea, Phaseolus, Pistachia, Pisum, Pyrus, Prunus, Raphanus, Ricinus, Secale, Senecio, Sinapis, Solanum, Sorghum, Theobromus, Trigonella, Triticum, Vicia, Vitis, Vigna, and Zea.

[0100] One of skill will recognize that after the expression cassette is stably incorporated in transgenic plants and confirmed to be operable, it can be introduced into other plants by sexual crossing. Any of a number of standard breeding techniques can be used, depending upon the species to be crossed.

[0101] Seed obtained from plants of the present invention can be analyzed according to well known procedures to identify plants with the desired trait. If antisense or other techniques are used to control Fie gene expression, Northern blot analysis can be used to screen for desired plants. In addition, the presence of fertilization independent reproductive development can be detected. Plants can be screened, for instance, for the ability to form embryo-less seed, form seed that abort after fertilization, or set fruit in the absence of fertilization. These procedures will depend, part on the particular plant species being used, but will be carried out according to methods well known to those of skill.

[0102] The following Examples are offered by way of illustration, not limitation.

EXAMPLE 1

[0103] The following example describes methods used to identify the fie mutants. The methods described here are generally as described in Ohad et al., Proc. Natl. Acad. Sci. USA 93:5319-5324 (1996).

Materials and Methods

[0104] Growth and Phenotype of Plants. Plants were grown under low humidity conditions (less than 50%) in glass houses under 16 hr light/8 hr dark photoperiods generated by supplemental lighting. Plants were grown at high humidity (greater than 80%) in a lighted incubator (Percival, Boone, Iowa).

[0105] To test for fertilization-independent development, flower buds from plants that had not yet begun to shed pollen (stage 12; (Smyth, D. R., et al., Plant Cell 2: 755-767 (1990))) were opened, immature anthers were removed, and the flower bud was covered with a plastic bag. Seven days later, the silique was measured, dissected, and the number of seed-like structures and degenerating ovules were counted. To determine the frequency of seed abortion following fertilization, siliques were harvested 10 days after self-pollination, dissected, and wild-type and aborted seeds were counted.

[0106] Genetic Mapping. Heterozygous FIE/fie (Landsberg erecta ecotype) plants were crossed as males with female plants (Columbia ecotype). Because the mutant fie allele is only transmitted through the male gametophyte, FIE/fie progeny were crossed as males a second time to female gl1/gl1 (Columbia ecotype) plants. Approximately fifty-five progeny were scored for the segregation of the wild-type FIE and mutant fie alleles and for alleles of molecular markers as described previously (Bell, C., et al., Genomics 19: 137-144 (1994)). This analysis indicated that fie3 is located at approximately position 30 on chromosome three, fie2 is located at approximately position 65 on chromosome two, and fie1 is located at approximately position 2 on chromosome one. Genetic recombination frequencies and map distances were calculated according to Koornneef and Stam (Koornneef, M., et al., Methods in Arabidopsis Research, pp. 83-99 (1992)) and Kosambi (Kosambi, Ann. Eugen., 12: 172-175 (1944)).

[0107] Light Microscopy. Nomarski photographs of whole-mount embryos and endosperm were obtained by fixing longitudinally slit siliques in an ethanol:acetic acid (9:1) solution overnight, followed by two washes in 90% and 70% ethanol, respectively. Siliques were cleared with a chloral hydrate:glycerol:water solution (8:1:2, w:v:v) (Berleth, T., et al., Devel 118: 575-587 (1993)). Whole mount preparations were fixed and stained with hematoxylin (Beeckman, T., et al., Plant Mol Biol Rep 12: 37-42 (1994)). Embryo and endosperm were photographed with a Zeiss Axioskop microscope (Carl Zeiss, Inc., Oberkochen, Germany) using Nomarski optics that permits visualization of optical sections within the seed.

[0108] GUS Histochemical Assays. GUS activity was detected histochemically as described previously by (Beeckman, T., et al., Plant Mol Biol Rep 12: 37-42 (1994)).

[0109] Image Processing. Photographs were scanned using a Microtek scanner. Pictures were processed for publication using Adobe Photoshop 3.0 and printed on a Tektronix Phaser 400 color printer.

Results

[0110] Isolation of Mutant Lines. To begin to understand mechanisms that initiate reproductive development, we generated mutant Arabidopsis plants that undergo several reproductive processes in the absence of fertilization. Arabidopsis plants homozygous for the conditional male sterile pop1 mutation (Preuss, D., et al., Genes and Devel 7: 974-985 (1993)) were used as the parental strain (Landsberg erecta ecotype). Fertility in pop1 plants is sensitive to humidity because pop1 pollen do not hydrate properly due to a defect in wax biosynthesis. When grown at permissive condition, high relative humidity (>80%), pop1 plants were male fertile and produced long siliques with many viable seeds. By contrast, when grown at non-permissive condition, low relative humidity (<50%), pop1 plants were male sterile and produced short siliques with no seeds. Thus, silique elongation is a marker for reproductive events. To isolate mutations, homozygous pop1 seeds were mutagenized with ethylmethansulfonate (EMS) and approximately 50,000 M1 plants were screened for silique elongation at non-permissive conditions. Rare M1 plants were identified that displayed heterozygous sectors with elongated siliques. These plants were transferred to permissive conditions to insure the production of viable M2 seed. Plants from M2 and M3 families grown at non-permissive conditions were rechecked for non-sectored silique elongation. To eliminate any effects of the pop1 mutation, or other EMS-induced lesions on the mutant phenotype, mutant plants were backrossed twice, as males, to wild-type plants. After removing the pop1 mutation, fertilization-independent phenotypes were confirmed after manual removal of anthers from immature flowers before pollen was shed. A total of twelve lines were identified that displayed elongated siliques in the absence of fertilization.

[0111] Fertilization-Independent Endosperm, Seed Coat and Silique Development. In a representative line chosen for further study, heterozygous plants produced by back crosses to wild-type plants generated elongated siliques after anther removal with numerous seed-like structures. These results indicated that heterozygous mutant plants were capable of silique elongation and seed-like structure development in the absence of fertilization. We compared the development of the mutant seed-like structures to that of wild-type seeds. After fertilization, the endosperm nucleus replicated and daughter nuclei migrated into the expanding central cell. Ultimately, a syncytium of endosperm nuclei was produced. Nuclear divisions of the endosperm preceded the zygotic divisions that formed the globular stage embryo. Embryo, endosperm or seed coat development did not occur in wild-type plants in the absence of fertilization. Development of the ovule and female gametophyte in heterozygous mutant plants was normal. Just prior to flower opening, female gametophytes in these plants contained a single, prominent central cell nucleus. Subsequently, in the absence of fertilization, central cells with two large nuclei were detected. Further divisions resulted in the production of additional nuclei that migrated into the expanded central cell. Later in development, a nuclear syncytium was formed with abundant endosperm nuclei. These results indicated that the central cell in mutant female gametophytes initiated endosperm development in the absence of fertilization. We have named this mutation fie for fertilization-independent endosperm. By contrast, replication of other nuclei in fie female gametophytes (egg, synergid, or antipodal) was not detected. Thus, the fie mutation specifically affects replication of the central cell nucleus.

[0112] We analyzed the frequency of multinucleate central cell formation in fie female gametophytes by comparing the percentage of multinucleate central cells at three, five, and six days after emasculation of heterozygous FIE/fie and control wild-type flowers. At each time point, only 3% to 5% of wild-type central cells had more than one nucleus. Because none had more than two nuclei, most likely, these represented central cells with haploid nuclei that had not fused during female gametophyte development. By contrast, the percentage of central cells in female gametophytes from FIE/fie siliques with two or more nuclei increased from 21% to 47% over the same time period. These results indicated that the fie mutation caused a significant increase in formation of multinucleate central cells in the absence of fertilization. The fact that close to 50% of the female gametophytes in heterozygous plants had multinucleate central cells suggested that fie is a gametophytic mutation because a 1:1 segregation of wild-type and mutant fie alleles occurs during meiosis.

[0113] We compared the fertilization-independent development of the maternal seed coat in FIE/fie seed-like structures to that of fertilized wild-type seeds. The seed coat in wild-type Arabidopsis is generated by the integuments of the ovule and surrounds the developing embryo and endosperm. Similarly, FIE/fie ovule integuments formed a seed coat that surrounded the developing mutant endosperm. These results indicated that the fie mutation activated both endosperm development and maternal sporophytic seed coat and silique differentiation that support reproduction. No other effects on sporophytic growth and development were detected in FIE/fie plants.

[0114] The fie3 Mutant Allele Is Not Transmitted by the Female Gametophyte to the Next Generation. To understand the mode of inheritance of the fie mutation, we analyzed the progeny of reciprocal crosses. FIE3/fie3 females, crossed to wild-type males, produced siliques with approximately equal numbers of viable seeds with normal green embryos and nonviable white seeds with embryos aborted at the heart stage (344:375, 1:1, c2=1.3, P>0.2). Viable seeds from this cross were germinated and all 120 F1 progeny generated were wild-type. That is, none of the F1 progeny had significant levels of F2 aborted seeds in their siliques after self-pollination. Nor did the F1 progeny demonstrate fertilization-independent development. This indicated that presence of the fie mutant allele in the female gametophyte, even when the male provided a wild-type allele, resulted in embryo abortion. Thus, the fie mutation is not transmitted by the female gametophyte to the next generation. To study transmission of fie through the male gametophyte, we pollinated female wild-type plants with pollen from male FIE3/fie3 plants. Siliques from these crosses contained no aborted F1 seed. F1 plants were examined and a 1:1 segregation of wild-type and FIE3/fie3 genotype was observed (62:58, c2=0.13, P>0.5). This indicated that wild-type and mutant fie3 alleles were transmitted by the male gametophyte with equal efficiency. That is, fie does not affect male gametophyte, or pollen grain, function. Results from reciprocal crosses were verified by analyzing the progeny from self-pollinated FIE3/fie3 plants. Self-pollinated siliques displayed 1:1 segregation of normal and aborted seeds (282:286, c2=0.03, P>0.8). Viable seed from self-pollinated siliques were germinated and a 1:1 (71:64, c2=0.36, P>0.5) segregation of wild-type and FIE3/fie3 progeny was observed. These results confirmed that inheritance of a fie mutant allele by the female gametophyte resulted in embryo abortion, and that inheritance of a fie mutant allele by the male gametophyte did not affect pollen function. Thus, the wild-type FIE3 allele probably carries out a function unique to the female gametophyte and does not appear to be needed for male fertility.

[0115] In contrast, fie1 and fie2 mutant alleles were transmitted at low frequencies (about 1% of normal) through the female gametophyte. In this way, fie1 homozygous mutants and fie2 homozygous mutants were obtained that appeared to display normal vegetative growth and development.

Discussion

[0116] In wild-type plants, fertilization initiates embryogenesis and endosperm formation, and activates maternal seed coat and silique development. The results presented here indicate that specific aspects of plant reproductive development can occur in FIE/fie plants in the absence of fertilization. These include silique elongation, seed coat formation, and endosperm development. Morphological analysis shows that early aspects of fertilization-independent fie endosperm development closely resemble fertilized wild-type endosperm development. First, the fie central cell nucleus is stimulated to undergo replication. Second, nuclei that are produced migrate from the micropylar end of the central cell and take up new positions in the central cell. Third, the developing fie central cell expands to form an endosperm cavity. Thus, the requirement for fertilization to initiate these early events in endosperm formation has been eliminated by the fie mutation. This suggests that FIE plays a role in a signal transduction pathway that links fertilization with the onset of central cell nuclear replication and early endosperm development.

[0117] Mechanisms for Regulation of Endosperm Development by FIE. One can envision two possible mechanisms for how FIE regulates replication of the central cell nucleus in response to fertilization. The protein encoded by the FIE gene may be involved in a positive regulatory interaction. In this model, FIE is required for the central cell to initiate endosperm development. Normally, fertilization is needed for the presence of active FIE protein. The fie mutation results in the presence of active protein in the absence of fertilization. Alternatively, FIE may by involved in a negative regulatory interaction. In this model, the function of FIE protein is to prevent the central cell from initiating endosperm development, and fertilization results in the inactivation of FIE protein. The fie mutation results in the production of inactive protein, so that fertilization is no longer required to initiate endosperm development. However, complementation experiments using transgenic plants indicate that FIE1 and FIE3 alleles are dominant over their respective mutant alleles. This indicates that the wild-type allele is involved in a negative regulatory interaction. Recently, it has been shown that cyclin-dependent kinase complexes, related to those that function in mammals, control the induction of DNA synthesis and mitosis in maize endosperm (Grafi, G. et al., Science 269: 1262-1264 (1995)). Because fie stimulates replication of the central cell, fie may, either directly or indirectly, impinge upon cell cycle control of the central cell nucleus, allowing replication to take place in the absence of fertilization.

[0118] Communication between the fie Female Gametophyte and the Sporophytic Ovule and Carpels. The analysis of FIE/fie mutant plants has provided clues about interactions between endosperm and maternal sporophytic tissues. FIE/fie ovule integuments surrounding a mutant fie female gametophyte initiate seed coat development, whereas FIE/fie integuments in contact with a quiescent wild-type female gametophyte do not develop. This suggests that the FIE/fie ovule integuments initiate seed coat differentiation in response to a signal produced by the fie female gametophyte. We propose that the source of the signal is the mutant fie central cell that has initiated endosperm development, although we cannot rule out the participation of other cells in the fie female gametophyte. In wild-type plants, most likely, fertilization of the central cell produces an endosperm that activates seed coat development. This is consistent with experiments showing that the maize endosperm interacts with nearby maternal cells (Miller, M. E., et al., Plant Cell 4: 297-305 (1992)). FIE/fie plants also display fertilization-independent elongation of the ovary to form the silique. We propose that a signal is produced by the developing seed-like structures to initiate silique elongation. This is in agreement with experiments suggesting that seeds are the source of hormones, auxins and gibberellins, that activate fruit development (Lee, T. D. Plant Reproductive Ecology, pp. 179-202 (1988)). Taken together, these results suggest that the fertilized female gametophyte activates maternal developmental programs.

[0119] Relationship between fie and Apomixis. Certain plant species display aspects of fertilization-independent reproductive development, including apomictic generation of embryo and endosperm, and development of the maternal seed coat and fruit (reviewed in (Koltunow, a. Plant Cell 5: 1425-1437 (1993)). The fie mutation reveals that Arabidopsis, a sexually reproducing plant, has the genetic potential for aspects of fertilization-independent reproductive development. It is not known whether the mechanism of fertilization-independent endosperm development conferred by the fie mutation is the same as autonomous endosperm formation observed in certain apomictic plant species. However, the fact that the fie phenotype is caused by a single genetic locus substantiates the view that the number of genetic differences between sexually and asexually reproducing plants is small (Koltunow, a. M., et al., Plant Physiol 108:1345-1352 (1995)).

EXAMPLE 2

[0120] This example describes cloning of two Fie genes, Fie1 and Fie3.

[0121] Cloning The FIE3 Gene.

[0122] a. Mapping the position of the fie3 gene genetically. The fie3 mutation was initially mapped to position 30 on chromosome 3, between AXR2 (auxin resistant dwarf) and EMB29 (embryo lethal). Next, two sets of F2 plants with recombination breakpoints in the fie3 gene region were obtained. One set was between emb29 and fie3 and the other set was between axr2 and fie3. As shown in FIG. 1A, these recombinants were used to map the fie3 gene relative to molecular markers (NDR, CH18, CH18S, BO20, AG20, KN1 and E13F12) that were obtained from overlapping YAC (yUP13F12), BAC (T1B4 and T4N1) and cosmid clones (FIG. 1A). YAC and BAC clones were obtained from the Arabidopsis Stock Center (Ohio State University, USA). Cosmid subclones were generated in my laboratory. As shown in FIG. 1A and 1B, this genetic analysis indicates that the fie3 gene resides within the 25 Kb region between the BO20 and AG20 markers.

[0123] b. Mapping the position of the fie3 gene by complementation experiments. To more precisely localize the fie3 gene, we analyzed a series of overlapping cosmid clones (BO20, GM15, AG20 and EI12) that span the fie3 gene region. Each cosmid clone was tested for its ability to complement the fie3 mutation in transgenic plants. Only cosmid GM15 complemented the fie3 mutation (FIG. 1A). These results indicate that an essential portion of the fie3 gene is in the 10 Kb region that is unique to cosmid GM15. As shown in FIG. 1B, we have cloned DNA that spans this essential portion of the fie3 gene and have determined its DNA sequence. As shown in FIG. 2, analysis of the sequence using the GENSCANW program revealed a gene with an open reading frame. The predicted cDNA sequence and predicted amino acid sequence are shown in SEQ ID NO:3 and SEQ ID NO:4, respectively. Comparing the predicted amino acid sequence to those in public data bases revealed significant homology to the WD40 family of Polycomb Group genes, and in particular, the “extra sex combs” gene in Drosophila. FIG. 3 shows the position of primers used to PCR amplify this region. SEQ ID NO:5 provides the genomic DNA sequence of the WD40/Polycomb gene, plus approximately 3.8 Kb of 5′-flanking sequences and 0.3 Kb of 3′-flanking sequences, plus the sequence of primers used to PCR amplify this region. The transcription start site in SEQ ID NO:5 is at position 3,872. Thus, the promoter sequence for FIE3 is located between position 1 and 3,872. The 5′-flanking and 3′-flanking regions contain regulatory DNA sequences that control the expression of this gene.

[0124] Cloning the FIE1 Gene.

[0125] a. Mapping the position of the FIE1 gene genetically. The fie1 mutation was initially mapped to position 3 on chromosome 1, between AXR3 (auxin resistant dwarf) and EMB60 (embryo lethal). Next, two sets of F2 plants with recombination breakpoints in the FIE1 gene region were obtained. One set was between emb60 and fie3 and the other set was between axr3 and fie3. These recombinants were used to map the fie3 gene relative to molecular markers (FIG. 4) that were obtained from an overlapping series of YAC and BAC clones from the Arabidopsis Stock Center (Ohio State University, USA).

[0126] b. Mapping the position of the FIE1 gene by complementation experiments. To more precisely localize the FIE1 gene, a series of overlapping cosmid clones (2-9, 6-22, 2-8) that span the FIE1 gene region were analyzed (FIG. 4). Each cosmid clone was tested for its ability to complement the fie1 mutation in transgenic plants. Only cosmid 6-22 complemented the fie1 mutation. The cosmids were analyzed for genes with open reading frames. FIG. 5 shows that a single gene was present on the complementing cosmid (6-22) that was not fully encoded on either of the non-complementing cosmids (2-9 and 2-8). By RTPCR and 5′-race, the cDNA sequence of this gene and predicted amino acid of its protein were obtained (SEQ ID NO: 1 and SEQ ID NO:2, respectively). Comparison of the predicted amino acid sequence to those in public data bases revealed significant homology to the SET family of Polycomb Group Genes (e.g., Enhancer of Zeste in Drosophila and Curly Leaf in Arabiopsis). We compared the wild-type and fie1 mutant sequence in 6-22. The only difference is a single base pair change that creates a premature translation stop codon in the 5′-end of the set/polycomb group gene. The base pair change is at position 823 (C→T) on the cDNA sequence shown in SEQ ID NO: 1.

[0127] SEQ ID NO:6 shows the genomic sequence of the FIE1 SET/polycomb gene, plus approximately 2 Kb of 5′-flanking sequences and approximately 0.7 Kb of 3 ′-flanking sequences. The translation start site is located at position 2036 of SEQ ID NO:6. Thus, the promoter sequence is located between position 1 and position 2036.

[0128] The above examples are provided to illustrate the invention but not to limit its scope. Other variants of the invention will be readily apparent to one of ordinary skill in the art and are encompassed by the appended claims. All publications, patents, and patent applications cited herein are hereby incorporated by reference.

1 324 2136 base pairs nucleic acid single linear cDNA CDS 43..2112 /product= “Arabidopsis fertilization-independent endosperm 1 (FIE1)” 1 AACATCAGAG AAGACGAGAA AAAAAGAAGA GGCGAGTGGT TA ATG GAG AAG GAA 54 Met Glu Lys Glu 1 AAC CAT GAG GAC GAT GGT GAG GGT TTG CCA CCC GAA CTA AAT CAG ATA 102 Asn His Glu Asp Asp Gly Glu Gly Leu Pro Pro Glu Leu Asn Gln Ile 5 10 15 20 AAA GAG CAA ATC GAA AAG GAG AGA TTT CTG CAT ATC AAG AGA AAA TTC 150 Lys Glu Gln Ile Glu Lys Glu Arg Phe Leu His Ile Lys Arg Lys Phe 25 30 35 GAG CTG AGA TAC ATT CCA AGT GTG GCT ACT CAT GCT TCA CAC CAT CAA 198 Glu Leu Arg Tyr Ile Pro Ser Val Ala Thr His Ala Ser His His Gln 40 45 50 TCG TTT GAC TTA AAC CAG CCC GCT GCA GAG GAT GAT AAT GGA GGA GAC 246 Ser Phe Asp Leu Asn Gln Pro Ala Ala Glu Asp Asp Asn Gly Gly Asp 55 60 65 AAC AAA TCA CTT TTG TCG AGA ATG CAA AAC CCA CTT CGT CAT TTC AGT 294 Asn Lys Ser Leu Leu Ser Arg Met Gln Asn Pro Leu Arg His Phe Ser 70 75 80 GCC TCA TCT GAT TAT AAT TCT TAC GAA GAT CAA GGT TAT GTT CTT GAT 342 Ala Ser Ser Asp Tyr Asn Ser Tyr Glu Asp Gln Gly Tyr Val Leu Asp 85 90 95 100 GAG GAT CAA GAT TAT GCT CTT GAA GAA GAT GTA CCA TTA TTT CTT GAT 390 Glu Asp Gln Asp Tyr Ala Leu Glu Glu Asp Val Pro Leu Phe Leu Asp 105 110 115 GAA GAT GTA CCA TTA TTA CCA AGT GTC AAG CTT CCA ATT GTT GAG AAG 438 Glu Asp Val Pro Leu Leu Pro Ser Val Lys Leu Pro Ile Val Glu Lys 120 125 130 CTA CCA CGA TCC ATT ACA TGG GTC TTC ACC AAA AGT AGC CAG CTG ATG 486 Leu Pro Arg Ser Ile Thr Trp Val Phe Thr Lys Ser Ser Gln Leu Met 135 140 145 GCT GAA AGT GAT TCT GTG ATT GGT AAG AGA CAA ATC TAT TAT TTG AAT 534 Ala Glu Ser Asp Ser Val Ile Gly Lys Arg Gln Ile Tyr Tyr Leu Asn 150 155 160 GGT GAG GCA CTA GAA TTG AGC AGT GAA GAA GAT GAG GAA GAT GAA GAA 582 Gly Glu Ala Leu Glu Leu Ser Ser Glu Glu Asp Glu Glu Asp Glu Glu 165 170 175 180 GAA GAT GAG GAA GAA ATC AAG AAA GAA AAA TGC GAA TTT TCT GAA GAT 630 Glu Asp Glu Glu Glu Ile Lys Lys Glu Lys Cys Glu Phe Ser Glu Asp 185 190 195 GTA GAC CGA TTT ATA TGG ACG GTT GGG CAG GAC TAT GGT TTG GAT GAT 678 Val Asp Arg Phe Ile Trp Thr Val Gly Gln Asp Tyr Gly Leu Asp Asp 200 205 210 CTG GTC GTG CGG CGT GCT CTC GCC AAG TAC CTC GAA GTG GAT GTT TCG 726 Leu Val Val Arg Arg Ala Leu Ala Lys Tyr Leu Glu Val Asp Val Ser 215 220 225 GAC ATA TTG GAA AGA TAC AAT GAA CTC AAG CTT AAG AAT GAT GGA ACT 774 Asp Ile Leu Glu Arg Tyr Asn Glu Leu Lys Leu Lys Asn Asp Gly Thr 230 235 240 GCT GGT GAG GCT TCT GAT TTG ACA TCC AAG ACA ATA ACT ACT GCT TTC 822 Ala Gly Glu Ala Ser Asp Leu Thr Ser Lys Thr Ile Thr Thr Ala Phe 245 250 255 260 CAG GAT TTT GCT GAT AGA CGT CAT TGC CGT CGT TGC ATG ATA TTC GAT 870 Gln Asp Phe Ala Asp Arg Arg His Cys Arg Arg Cys Met Ile Phe Asp 265 270 275 TGT CAT ATG CAT GAG AAG TAT GAG CCC GAG TCT AGA TCC AGC GAA GAC 918 Cys His Met His Glu Lys Tyr Glu Pro Glu Ser Arg Ser Ser Glu Asp 280 285 290 AAA TCT AGT TTG TTT GAG GAT GAA GAT AGA CAA CCA TGC AGT GAG CAT 966 Lys Ser Ser Leu Phe Glu Asp Glu Asp Arg Gln Pro Cys Ser Glu His 295 300 305 TGT TAC CTC AAG GTG AGG AGT GTG ACA GAA GCT GAT CAT GTG ATG GAT 1014 Cys Tyr Leu Lys Val Arg Ser Val Thr Glu Ala Asp His Val Met Asp 310 315 320 AAT GAT AAC TCT ATA TCA AAC AAG ATT GTG GTC TCA GAT CCA AAC AAC 1062 Asn Asp Asn Ser Ile Ser Asn Lys Ile Val Val Ser Asp Pro Asn Asn 325 330 335 340 ACT ATG TGG ACG CCT GTA GAG AAG GAT CTT TAC TTG AAA GGA ATT GAG 1110 Thr Met Trp Thr Pro Val Glu Lys Asp Leu Tyr Leu Lys Gly Ile Glu 345 350 355 ATA TTT GGG AGA AAC AGT TGT GAT GTT GCA TTA AAC ATA CTT CGG GGG 1158 Ile Phe Gly Arg Asn Ser Cys Asp Val Ala Leu Asn Ile Leu Arg Gly 360 365 370 CTT AAG ACG TGC CTA GAG ATT TAC AAT TAC ATG CGC GAA CAA GAT CAA 1206 Leu Lys Thr Cys Leu Glu Ile Tyr Asn Tyr Met Arg Glu Gln Asp Gln 375 380 385 TGT ACT ATG TCA TTA GAC CTT AAC AAA ACT ACA CAA AGA CAC AAT CAG 1254 Cys Thr Met Ser Leu Asp Leu Asn Lys Thr Thr Gln Arg His Asn Gln 390 395 400 GTT ACC AAA AAA GTA TCT CGA AAA AGT AGT AGG TCG GTC CGC AAA AAA 1302 Val Thr Lys Lys Val Ser Arg Lys Ser Ser Arg Ser Val Arg Lys Lys 405 410 415 420 TCG AGA CTC CGA AAA TAT GCT CGT TAT CCG CCT GCT TTA AAG AAA ACA 1350 Ser Arg Leu Arg Lys Tyr Ala Arg Tyr Pro Pro Ala Leu Lys Lys Thr 425 430 435 ACT AGT GGA GAA GCT AAG TTT TAT AAG CAC TAC ACA CCA TGC ACT TGC 1398 Thr Ser Gly Glu Ala Lys Phe Tyr Lys His Tyr Thr Pro Cys Thr Cys 440 445 450 AAG TCA AAA TGT GGA CAG CAA TGC CCT TGT TTA ACT CAC GAA AAT TGC 1446 Lys Ser Lys Cys Gly Gln Gln Cys Pro Cys Leu Thr His Glu Asn Cys 455 460 465 TGC GAG AAA TAT TGC GGG TGC TCA AAG GAT TGC AAC AAT CGC TTT GGA 1494 Cys Glu Lys Tyr Cys Gly Cys Ser Lys Asp Cys Asn Asn Arg Phe Gly 470 475 480 GGA TGT AAT TGT GCA ATT GGC CAA TGC ACA AAT CGA CAA TGT CCT TGT 1542 Gly Cys Asn Cys Ala Ile Gly Gln Cys Thr Asn Arg Gln Cys Pro Cys 485 490 495 500 TTT GCT GCT AAT CGT GAA TGC GAT CCA GAT CTT TGT CGG AGT TGT CCT 1590 Phe Ala Ala Asn Arg Glu Cys Asp Pro Asp Leu Cys Arg Ser Cys Pro 505 510 515 CTT AGC TGT GGA GAT GGC ACT CTT GGT GAG ACA CCA GTG CAA ATC CAA 1638 Leu Ser Cys Gly Asp Gly Thr Leu Gly Glu Thr Pro Val Gln Ile Gln 520 525 530 TGC AAG AAC ATG CAA TTC CTC CTT CAA ACC AAT AAA AAG ATT CTC ATT 1686 Cys Lys Asn Met Gln Phe Leu Leu Gln Thr Asn Lys Lys Ile Leu Ile 535 540 545 GGA AAG TCT GAT GTT CAT GGA TGG GGT GCA TTT ACA TGG GAC TCT CTT 1734 Gly Lys Ser Asp Val His Gly Trp Gly Ala Phe Thr Trp Asp Ser Leu 550 555 560 AAA AAG AAT GAG TAT CTC GGA GAA TAT ACT GGA GAA CTG ATC ACT CAT 1782 Lys Lys Asn Glu Tyr Leu Gly Glu Tyr Thr Gly Glu Leu Ile Thr His 565 570 575 580 GAT GAA GCT AAT GAG CGT GGG AGA ATA GAA GAT CGG ATT GGT TCT TCC 1830 Asp Glu Ala Asn Glu Arg Gly Arg Ile Glu Asp Arg Ile Gly Ser Ser 585 590 595 TAC CTC TTT ACC TTG AAT GAT CAG CTC GAA ATC GAT GCT CGC CGT AAA 1878 Tyr Leu Phe Thr Leu Asn Asp Gln Leu Glu Ile Asp Ala Arg Arg Lys 600 605 610 GGA AAC GAG TTC AAA TTT CTC AAT CAC TCA GCA AGA CCT AAC TGC TAC 1926 Gly Asn Glu Phe Lys Phe Leu Asn His Ser Ala Arg Pro Asn Cys Tyr 615 620 625 GCC AAG TTG ATG ATT GTG AGA GGA GAT CAG AGG ATT GGT CTA TTT GCG 1974 Ala Lys Leu Met Ile Val Arg Gly Asp Gln Arg Ile Gly Leu Phe Ala 630 635 640 GAG AGA GCA ATC GAA GAA GGT GAG GAG CTT TTC TTC GAC TAC TGC TAT 2022 Glu Arg Ala Ile Glu Glu Gly Glu Glu Leu Phe Phe Asp Tyr Cys Tyr 645 650 655 660 GGA CCA GAA CAT GCG GAT TGG TCG CGT GGT CGA GAA CCT AGA AAG ACT 2070 Gly Pro Glu His Ala Asp Trp Ser Arg Gly Arg Glu Pro Arg Lys Thr 665 670 675 GGT GCT TCT AAA AGG TCT AAG GAA GCC CGT CCA GCT CGT TAGTTTTTGA 2119 Gly Ala Ser Lys Arg Ser Lys Glu Ala Arg Pro Ala Arg 680 685 TCTGAGGAGA AGCAGCA 2136 689 amino acids amino acid linear protein 2 Met Glu Lys Glu Asn His Glu Asp Asp Gly Glu Gly Leu Pro Pro Glu 1 5 10 15 Leu Asn Gln Ile Lys Glu Gln Ile Glu Lys Glu Arg Phe Leu His Ile 20 25 30 Lys Arg Lys Phe Glu Leu Arg Tyr Ile Pro Ser Val Ala Thr His Ala 35 40 45 Ser His His Gln Ser Phe Asp Leu Asn Gln Pro Ala Ala Glu Asp Asp 50 55 60 Asn Gly Gly Asp Asn Lys Ser Leu Leu Ser Arg Met Gln Asn Pro Leu 65 70 75 80 Arg His Phe Ser Ala Ser Ser Asp Tyr Asn Ser Tyr Glu Asp Gln Gly 85 90 95 Tyr Val Leu Asp Glu Asp Gln Asp Tyr Ala Leu Glu Glu Asp Val Pro 100 105 110 Leu Phe Leu Asp Glu Asp Val Pro Leu Leu Pro Ser Val Lys Leu Pro 115 120 125 Ile Val Glu Lys Leu Pro Arg Ser Ile Thr Trp Val Phe Thr Lys Ser 130 135 140 Ser Gln Leu Met Ala Glu Ser Asp Ser Val Ile Gly Lys Arg Gln Ile 145 150 155 160 Tyr Tyr Leu Asn Gly Glu Ala Leu Glu Leu Ser Ser Glu Glu Asp Glu 165 170 175 Glu Asp Glu Glu Glu Asp Glu Glu Glu Ile Lys Lys Glu Lys Cys Glu 180 185 190 Phe Ser Glu Asp Val Asp Arg Phe Ile Trp Thr Val Gly Gln Asp Tyr 195 200 205 Gly Leu Asp Asp Leu Val Val Arg Arg Ala Leu Ala Lys Tyr Leu Glu 210 215 220 Val Asp Val Ser Asp Ile Leu Glu Arg Tyr Asn Glu Leu Lys Leu Lys 225 230 235 240 Asn Asp Gly Thr Ala Gly Glu Ala Ser Asp Leu Thr Ser Lys Thr Ile 245 250 255 Thr Thr Ala Phe Gln Asp Phe Ala Asp Arg Arg His Cys Arg Arg Cys 260 265 270 Met Ile Phe Asp Cys His Met His Glu Lys Tyr Glu Pro Glu Ser Arg 275 280 285 Ser Ser Glu Asp Lys Ser Ser Leu Phe Glu Asp Glu Asp Arg Gln Pro 290 295 300 Cys Ser Glu His Cys Tyr Leu Lys Val Arg Ser Val Thr Glu Ala Asp 305 310 315 320 His Val Met Asp Asn Asp Asn Ser Ile Ser Asn Lys Ile Val Val Ser 325 330 335 Asp Pro Asn Asn Thr Met Trp Thr Pro Val Glu Lys Asp Leu Tyr Leu 340 345 350 Lys Gly Ile Glu Ile Phe Gly Arg Asn Ser Cys Asp Val Ala Leu Asn 355 360 365 Ile Leu Arg Gly Leu Lys Thr Cys Leu Glu Ile Tyr Asn Tyr Met Arg 370 375 380 Glu Gln Asp Gln Cys Thr Met Ser Leu Asp Leu Asn Lys Thr Thr Gln 385 390 395 400 Arg His Asn Gln Val Thr Lys Lys Val Ser Arg Lys Ser Ser Arg Ser 405 410 415 Val Arg Lys Lys Ser Arg Leu Arg Lys Tyr Ala Arg Tyr Pro Pro Ala 420 425 430 Leu Lys Lys Thr Thr Ser Gly Glu Ala Lys Phe Tyr Lys His Tyr Thr 435 440 445 Pro Cys Thr Cys Lys Ser Lys Cys Gly Gln Gln Cys Pro Cys Leu Thr 450 455 460 His Glu Asn Cys Cys Glu Lys Tyr Cys Gly Cys Ser Lys Asp Cys Asn 465 470 475 480 Asn Arg Phe Gly Gly Cys Asn Cys Ala Ile Gly Gln Cys Thr Asn Arg 485 490 495 Gln Cys Pro Cys Phe Ala Ala Asn Arg Glu Cys Asp Pro Asp Leu Cys 500 505 510 Arg Ser Cys Pro Leu Ser Cys Gly Asp Gly Thr Leu Gly Glu Thr Pro 515 520 525 Val Gln Ile Gln Cys Lys Asn Met Gln Phe Leu Leu Gln Thr Asn Lys 530 535 540 Lys Ile Leu Ile Gly Lys Ser Asp Val His Gly Trp Gly Ala Phe Thr 545 550 555 560 Trp Asp Ser Leu Lys Lys Asn Glu Tyr Leu Gly Glu Tyr Thr Gly Glu 565 570 575 Leu Ile Thr His Asp Glu Ala Asn Glu Arg Gly Arg Ile Glu Asp Arg 580 585 590 Ile Gly Ser Ser Tyr Leu Phe Thr Leu Asn Asp Gln Leu Glu Ile Asp 595 600 605 Ala Arg Arg Lys Gly Asn Glu Phe Lys Phe Leu Asn His Ser Ala Arg 610 615 620 Pro Asn Cys Tyr Ala Lys Leu Met Ile Val Arg Gly Asp Gln Arg Ile 625 630 635 640 Gly Leu Phe Ala Glu Arg Ala Ile Glu Glu Gly Glu Glu Leu Phe Phe 645 650 655 Asp Tyr Cys Tyr Gly Pro Glu His Ala Asp Trp Ser Arg Gly Arg Glu 660 665 670 Pro Arg Lys Thr Gly Ala Ser Lys Arg Ser Lys Glu Ala Arg Pro Ala 675 680 685 Arg 693 base pairs nucleic acid single linear cDNA CDS 1..693 /product= “Arabidopsis fertilization-independent endosperm 3 (FIE3)” 3 ATG TCC TCT GGA GAG CAG AAG GAA GAG TCG TTT TAC ACG GTA AGT TGG 48 Met Ser Ser Gly Glu Gln Lys Glu Glu Ser Phe Tyr Thr Val Ser Trp 1 5 10 15 GCG TGT GGC GTT AAT GGG AAC CCA TAT GTT GCG GCT GGA GGA GTA AAA 96 Ala Cys Gly Val Asn Gly Asn Pro Tyr Val Ala Ala Gly Gly Val Lys 20 25 30 GGT ATA ATC CGA GTC ATT GAC GTC AAC AGT GAA ACG ATT CAT AAG AGT 144 Gly Ile Ile Arg Val Ile Asp Val Asn Ser Glu Thr Ile His Lys Ser 35 40 45 CTT GTG GGT CAT GGA GAT TCA GTG AAC GAA ATC AGG ACA CAA CCT TTA 192 Leu Val Gly His Gly Asp Ser Val Asn Glu Ile Arg Thr Gln Pro Leu 50 55 60 AAA CCT CAA CTT GTG ATT ACT GCT AGC AAG GAT TTT CAT CCG TCT GAT 240 Lys Pro Gln Leu Val Ile Thr Ala Ser Lys Asp Phe His Pro Ser Asp 65 70 75 80 ATT TAC CGC TTT GCT AGT TGT GGT ATG GAC ACC ACT ATT AAA ATA TGG 288 Ile Tyr Arg Phe Ala Ser Cys Gly Met Asp Thr Thr Ile Lys Ile Trp 85 90 95 TCA ATG AAA GAG TTT TGG ACG TAC GTC GAG AAG TCA TTC ACA TGG ACT 336 Ser Met Lys Glu Phe Trp Thr Tyr Val Glu Lys Ser Phe Thr Trp Thr 100 105 110 GAT GAT CCA TCA AAA TTC CCC ACA AAA TTT GTC CAA TTC CCT GTT AGT 384 Asp Asp Pro Ser Lys Phe Pro Thr Lys Phe Val Gln Phe Pro Val Ser 115 120 125 AAG TCA ATG ATG GTT AAG ATT AAT TCA TTT GGT GTA CTG TTA AAA CAC 432 Lys Ser Met Met Val Lys Ile Asn Ser Phe Gly Val Leu Leu Lys His 130 135 140 TTT ACT CTT GTG TTG TTC TAT CGG ATT TTA GAG TGT GGA CAA CGA GAT 480 Phe Thr Leu Val Leu Phe Tyr Arg Ile Leu Glu Cys Gly Gln Arg Asp 145 150 155 160 CCT GTT GTG GGA ACC ACA ACT GAA AGA GAA TTC TCC TGG CGA GGT AAT 528 Pro Val Val Gly Thr Thr Thr Glu Arg Glu Phe Ser Trp Arg Gly Asn 165 170 175 CAG GAA GGA AAG GTT TAT GTC TGG GAT TTG AAA AGT TGC CCT CCT GTT 576 Gln Glu Gly Lys Val Tyr Val Trp Asp Leu Lys Ser Cys Pro Pro Val 180 185 190 TTG ATT ACA AAG TTA TCA CAC AAT CAA TCA AAG TCT GTA ATC AGG CAA 624 Leu Ile Thr Lys Leu Ser His Asn Gln Ser Lys Ser Val Ile Arg Gln 195 200 205 ACA GCC ATG TCT GTC GAT GGA AGG TAT AAA TCC ATC TTC TCT CTC ACC 672 Thr Ala Met Ser Val Asp Gly Arg Tyr Lys Ser Ile Phe Ser Leu Thr 210 215 220 AAT GCA GTG AAA ATT TCT TAA 693 Asn Ala Val Lys Ile Ser 225 230 230 amino acids amino acid linear protein 4 Met Ser Ser Gly Glu Gln Lys Glu Glu Ser Phe Tyr Thr Val Ser Trp 1 5 10 15 Ala Cys Gly Val Asn Gly Asn Pro Tyr Val Ala Ala Gly Gly Val Lys 20 25 30 Gly Ile Ile Arg Val Ile Asp Val Asn Ser Glu Thr Ile His Lys Ser 35 40 45 Leu Val Gly His Gly Asp Ser Val Asn Glu Ile Arg Thr Gln Pro Leu 50 55 60 Lys Pro Gln Leu Val Ile Thr Ala Ser Lys Asp Phe His Pro Ser Asp 65 70 75 80 Ile Tyr Arg Phe Ala Ser Cys Gly Met Asp Thr Thr Ile Lys Ile Trp 85 90 95 Ser Met Lys Glu Phe Trp Thr Tyr Val Glu Lys Ser Phe Thr Trp Thr 100 105 110 Asp Asp Pro Ser Lys Phe Pro Thr Lys Phe Val Gln Phe Pro Val Ser 115 120 125 Lys Ser Met Met Val Lys Ile Asn Ser Phe Gly Val Leu Leu Lys His 130 135 140 Phe Thr Leu Val Leu Phe Tyr Arg Ile Leu Glu Cys Gly Gln Arg Asp 145 150 155 160 Pro Val Val Gly Thr Thr Thr Glu Arg Glu Phe Ser Trp Arg Gly Asn 165 170 175 Gln Glu Gly Lys Val Tyr Val Trp Asp Leu Lys Ser Cys Pro Pro Val 180 185 190 Leu Ile Thr Lys Leu Ser His Asn Gln Ser Lys Ser Val Ile Arg Gln 195 200 205 Thr Ala Met Ser Val Asp Gly Arg Tyr Lys Ser Ile Phe Ser Leu Thr 210 215 220 Asn Ala Val Lys Ile Ser 225 230 5801 base pairs nucleic acid single linear DNA (genomic) CDS 3872..5566 /product= “Arabidopsis fertilization-independent endosperm 1 (FIE3) WD40/polycomb gene genomic sequence” 5 TCTGAAGCAG CTAATCGATC CACTAATCTT GTGGAGATCG TGTGTTGCTT TGGTGCATAT 60 ATATACAAAT AGACAAATAC ATATGCGTTT ACATATATAT GTAAGCACGT ATTTAGAGAG 120 CAACAATAAG GCATGAGAAA TGTGATTATC GTCAAATCAT GATTGCTACA TGACAAATCG 180 ATCTTAATTT TGAAAAAGAG ACATTTAAAT ATTCAAAAAA CGGTAAAAAT TTCTTTAAGA 240 CCAACCATGG AAATAACATG AGAAGACTGA GAGGGAGATT AGAACTTACA ACAAGAGAAT 300 CTTTTTCCTT CAATATTTTT TTTAAACACT TTTCTTTTGT AGGGAATTTG ATAATATGAA 360 ATGGATAGAT TTTACTGCTT AATTTTTAAT CATTTTTTAT CAGAAACTTT TTCGTTTTAA 420 ATCTACGGCT AGAATTTTCG GTCGGTTTTA TACTTTATAT AGATGCTAGA TTTTTTTCTT 480 CTAGTCATCG TTTATTAGTA CAATTTTGTT TTTATATATT GATTACTTGA ATTTATAATA 540 GGATTGGTAC AAAGGTGGTA ATTATAAAGT GCATTTTTTT GGATATTGTT CAATTCAAAT 600 ATTTTTACTT AGATTCTCAA ACTATTGAAA AATATCCAAA ATATCCGGAA AATTTCAATT 660 TAATCGAATA AAAAAATTAG AATGGAAAGA ATAAAAAATT ATCGGGTACA ATTAGAAGAG 720 TAATGTGTTT AGTTTGGTTT TTACTCGGAT ACCAGTTCAG TTTTCACGTA TTATTCGATC 780 CTATAGGAGC AATTGTGAAT TAGTTGTGAG ATTTTGGGAG CATTCGCTTC CAGAACTTAG 840 TGCTAGGAGA AATGCTATTT TCCTATAAGA GTTGTACGAG GAAGCGAGCA AGTACACAAC 900 AACCACAAAA GCTTTCAATA CTTGTTTACT CCTAGGGTTT AAAACTAGAG GTTCTATAGA 960 TCTCTAAATT TTTTTGAACA AATGTGTTTT CCACACGTGA TATTCTACAA TACCACTCGA 1020 AAATTATCCA TAATTGCTTT AAACTATTTT TTTGTTTAAA TTATATAATT TGTACCGTTG 1080 TAAACTGATT ATTTCAAATT ATAATTAAAG CACTATAATT TCATATATTA CATTCAACAT 1140 ATATTAAAAT AAACTATAAC CATGTATTTT TTTGTCTTCC TTTCCTATAA ACATTGATTG 1200 GACTCTATCG TAAATTTTGT CGTTATCGCA AATTTTGTCG TTATCGATGA GTTTCTCAAA 1260 GTTTGGACCT TGATTATCTT GTTTGGAGAT GTTCAAATCG TTATATCCAA ATAGTGAACT 1320 TCTAATTTTC TTTTTTGATA ATGTGACTTA TTTGGAAAAG TATTCCAAAG TATTCAAATA 1380 AACCCTTTAA AAATCCATTA AATACATTTT AAATAAGTAA AATGCTCTCA ACGAAGAGAT 1440 ATCATGGTAA ATAACAACAG TGAGAGGATA AAATGTTAAA TCAATTTATT TACAACTTCA 1500 AATAGGCGGA CATCAAACCT ACTTAGCACA CTTTCTATTT TCAAATTGGT TATGGTTTGT 1560 CTATTAGTTG TTGCATCTAT GTTTTTTAAT TCTTATATCG GTGATCTTGA TTTTGTTTTG 1620 GTGTATCTAA AATCTATTTT AGTTAAAGTG CAAGAAAATA AAATAAAAAC TTAAGGTAAG 1680 AGATGAAAGT AAGCTTTAAA TAAAACAGAG CACTTCTATG GTCGATTATA GAGCCAAGTT 1740 CGTTCCTCCA TTTTGGCTTA ATGCAATATT ACAAGTAAAT CTTATAAAAC TTTCCATAAG 1800 TATCGTATTA CCCATGGATA CTATGATATA TAAACTCTCG GAGGTGTAGT CCAGAAGAAA 1860 TGATCCATAT TTGCATACAG TAAACTTGAT GGAAAAAATA TGTGGTACTG TTGGAATTGT 1920 AGCTATTGAG TATCAAATTT GAGAAAAAGG TAAAAAAATA TGTAAAATTT GGGTGGAAGA 1980 AAAGAATTAC ATAAAATTGA GAAATGTATG TAATTGACAA AATAATGTTT TCAAAACATA 2040 AAAACGTGAT ACCATTTAAA TCCAAACCTT ATATCATTTA ACCATTTTTA GTAAAACTAA 2100 TAGTAATGAA TGGTCAATAA TATAAGATTA CATATTAAAT AATTACTACT TTCAGAAAAT 2160 TTCAATCAAA TCTATAATAT TCCTTTGAAA AAAAAGAAAG ACAAATAGGT AAACTTCGAT 2220 CGTATCAATC AAAGAATATA TTTATTTTTC ATCGTAACGT TTAATTCTAA GTCCTATTAA 2280 AAAACGTTAA ATTTGATTTT TCTTACCATT TTTTTCTAAA AGGTGAGTTG TGTGTTGTGT 2340 CAGGTCCAAA ATAAAAGTTT GTCGTGAGGT CAAAATCTAC GGTTACAGTA ATTTTAATAA 2400 CCTGTGAATC TGTGTCTAAT CGAAAATTAC AAAACACCAG TTGTTGTTGC ATGAGAGACT 2460 TGTGAGCTTA GATTAGTGTG CGAGAGTCAG ACAGAGAGAG AGATTTCGAA TATCGAATGT 2520 CGAAGATAAC CTTAGGGAAC GAGTCAATAG TTGGGTCTTT GACTCCATCG AATAAGAAAT 2580 CGTACAAAGT GACGAATAGG ATTCAGGAAG GGAAGAAACC TTTGTATGCT GTTGTTTTCA 2640 ACTTCCTTGA TGCTCGTTTC TTCGATGTCT TCGTTACCGC TGGTGGAAAT CGGGTAAAAG 2700 ATCTCGACTT TCAATTCGAA ATCACTGTTT TCAATTCTGG GTCTGTTTAG GTTTTGATTC 2760 AGATTGATTG TAACATTAAG GCCTTTCCTT TTGTGTTTGA TTTTGGATTC TGATTTCTAG 2820 CCTTTAGTGA GATTAAAAGA TTGAAACTTT GCTTGATGCT ATAGTCTAAG ATTATGTAAC 2880 ATTTAGTTCA AACTTTCTGG TTTTGGAGAT TTTGTGGAAG ATATGGTTTT TGTTTTCTAA 2940 TTTAAAGTGA ACTCATTACC TTATACACTT GATTTGCATT CTGTTCTAAA AAAAATTGAA 3000 ACTTTGGTTG ATGTTGTTAG TCTGCTTATC TAAGGAGGTT CCTTTTGAAA CGGTCATCAA 3060 GTGAGTTATG AAGCGTTTAG TTTAAGCTTT CCTGTATTGG AGATTTTGTG GAAGTTATTT 3120 TTTTTTCTAA TTTTGAAACT AGATAGAGTG AAGTCATTAC CTTATACATT AGACTGCTCT 3180 ATTTTGTTTT CAATGTGGGT TCCGAATGTA CCTGATAGTG GCTCTTTAGG CTCATTTGTA 3240 TTCGTCGAAA CATCGATCGG ATACCCGTTT GGGCTTAGTA GGCTCTGATA CCGCGTAAAG 3300 TTCTCGGGTT CCATGAAAAA CCAATCGGTA ATGAGTGGAG TTAATTTGTA ATCGTCTTCG 3360 GTCGAGCATT TGGGATTAGT GGGCTTTGAT ACCATGTGAA AGTCCTTGGG GTCCAATCGG 3420 CAATGAGTAG AGTTAACTTG TAATCTTACA CACTTGGTTA GGTCTCATTC TCTTTATAAT 3480 GTTGTGTGCC TAACAGTTTC CGCACTAAGG TTGTTTGGTT GCTCAGTCTC AATATACTTA 3540 TCTTAACTAG TTGTAGTTTT TTTCATCTTT CCTAGTTTCC GTTGGATTTT AAATTGAATG 3600 ATTTACTAGT TAGAAATATT TGAGTTTCTC ATAGAAGCTT TAACCAAGGG GTTCTTTCAT 3660 TTAACCTTTA CTTAGCTAGT TCATGAATCT CATTACTGCC ATTGGTGTAT CTCTTATTAT 3720 GTAGATTACT CTGTACAATT GTCTCGGAGA TGGTGCCATA TCAGCATTGC AATCCTATGC 3780 TGATGAAGAT GTAAGGAAGC ATACATATTA GCTTTTCCAT CAAATTAAAG TAAGTGATGT 3840 TTCACTGAGG CCATTTGGTT ATATTTTGTC TATGTCCTCT GGAGAGCAGA AGGAAGAGTC 3900 GTTTTACACG GTAAGTTGGG CGTGTGGCGT TAATGGGAAC CCATATGTTG CGGCTGGAGG 3960 AGTAAAAGGT ATAATCCGAG TCATTGACGT CAACAGTGAA ACGATTCATA AGGTATTATT 4020 GCATTTTTAT GGATGTTCTA TGTATCCTAG CAAATGATTC TATATCTTTC TTGTATAATC 4080 TGTGCTCGCA AATGTGCAGA GTCTTGTGGG TCATGGAGAT TCAGTGAACG AAATCAGGAC 4140 ACAACCTTTA AAACCTCAAC TTGTGATTAC TGCTAGCAAG GTATATCTCT TGGCTTTCTT 4200 TTCTTCCTAA AGTATCCTGA CTTCTTTTTT ATTTGTTGGT GATTAAGAGC TGTTACGTTT 4260 TAATTGAATA AGGATGAATC TGTTCGTTTG TGGAATGTTG AAACTGGGAT ATGTATTTTG 4320 ATATTTGCTG GAGCTGGAGG TCATCGCTAT GAAGTTCTAA GTGTGGTGAG CCAATATTGT 4380 TTTATCTAAT TCAGTTAGTT TTCTACAATA ATATATAGAG ACAATGTTAA GGGGAACCAT 4440 CTTATTTTGA AAATTGTAGG ATTTTCATCC GTCTGATATT TACCGCTTTG CTAGTTGTGG 4500 TATGGACACC ACTATTAAAA TATGGTCAAT GAAAGGTACG ATCGAGCACA TATTGTAATA 4560 AACTTCCATT TTAAAAAACC TTTTGAGAAA AATGGCTTGT GGTTCGTTTG TATGATCTTC 4620 TTATTCTTTG GCTGTCTATA GAGTTTTGGA CGTACGTCGA GAAGTCATTC ACATGGACTG 4680 ATGATCCATC AAAATTCCCC ACAAAATTTG TCCAATTCCC TGTAAGTATT TTGTTTTAGC 4740 CTTGTCTTGT AACAACAAGT GACATACAAA TATTGGTGAT GGCCTTTGTA AATAACATTA 4800 CTTCTATATG TAGGTATTTA CAGCTTCCAT TCATACAAAT TATGTAGATT GTAACCGTTG 4860 GTTTGGTGAT TTTATCCTCT CAAAGGTTAG TAAGTCAATG ATGGTTAAGA TTAATTCATT 4920 TGGTGTACTG TTAAAACACT TTACTCTTGT GTTGTTCTAT CGGATTTTAG AGTGTGGACA 4980 ACGAGATCCT GTTGTGGGAA CCACAACTGA AAGAGAATTC TCCTGGCGAG GTTAGGATCT 5040 CATTGTTGCT CCAAACACAA CATAATCATT CATTTCATCA CATATATTTA CAGTTGAACT 5100 TTTTGTGGTT TGCAGGGAGC TTCAGATGTT CTATTAAGAT ACCCGGTTCC AATGTGTGAT 5160 ATTTGGTTTA TCAAGTTTTC TTGTGACCTC CATTTAAGTT CTGTTGCGAT AGGTAATCAG 5220 AGAGCTCGTT AGATACAAAT TTGCATTCTA TAGATAGATT ACTTCAACTT TTCTTATTCA 5280 TTTTGTGACA AATTACTCGC TGGTTTGTTA TCAGGTAATC AGGAAGGAAA GGTTTATGTC 5340 TGGGATTTGA AAAGTTGCCC TCCTGTTTTG ATTACAAAGT AAGTTAGTTT CGGATTCAGA 5400 TACAATGTTT GATCTTTAAG AAATGTTTTA GTCTTGACAT GATTTTCTGT TGCCATATAG 5460 GTTATCACAC AATCAATCAA AGTCTGTAAT CAGGCAAACA GCCATGTCTG TCGATGGAAG 5520 GTATAAATCC ATCTTCTCTC TCACCAATGC AGTGAAAATT TCTTAATGTT ATTTATGACT 5580 CAATAGTTAC TGTAAATCAA ACCAAACTTT GGATTCTGAC ACACTGTTTC TTCCATGGGA 5640 TTGTAGCACG ATTCTTGCTT GCTGCGAGGA CGGGACTATA TGGCGCTGGG ACGTGATTAC 5700 CAAGTAGCGG TCTGAGTCTT GTAGGAATTG ATGAATTAGG AGTGCGAAGA AATGAGATAT 5760 CCATTCTTTT ATTGTAATTC TGATCATGTT GCTACTCCCT G 5801 7015 base pairs nucleic acid single linear DNA (genomic) CDS 1..7014 /product= “Arabidopsis fertilization-independent endosperm 3 (FIE3) SET/polycomb gene genomic sequence reading frame 1” CDS 2..7015 /product= “Arabidopsis fertilization-independent endosperm 3 (FIE3) SET/polycomb gene genomic sequence reading frame 2” CDS 3..7013 /product= “Arabidopsis fertilization-independent endosperm 3 (FIE3) SET/polycomb gene genomic sequence reading frame 3” 6 GGATCCATTA TTTTTAAAAA TCAAATTTTT TCATATCTAT TATTTGTTTC AAAGAAAAAA 60 AAAACACACG ACGATTATCC ATCTGCCGGC TGTGTTCATC GGTAAACCTA TATTTTAAAA 120 CTGGTGGGCT TTTCATTACC ATAAGTTTGG ACATGTTTTT ATAATTTGAT GTATAGTGTA 180 GACCAAAAAA TAGAGAAATA AGAAAGGGAA CCTTTGTGGT GATTGTAACA AAACAGAAAT 240 CATTATATTG AATCATTCGA AAAGACGAAA AGATCAAACC TTTGTAGCTA GATGACCATA 300 GACGTGGCTG CCAATTACAG TCTTAATGCT TTTATATAGA TCTTTCTTAC ATCCTCTGTT 360 CCTTCACATT CAAGAAACAG TATCATCCCA TTTTCTTTCT TCTTCTCAGT GTTTCAATCT 420 TTGCGAATTA AGATGGAACA TGAAGAAACA CAAAAGAACA CAAGAAACAG CTGGTCCCTG 480 ATTCGACCAT TTCAAATGAT CTCCATTAGC TTTCTTAGCC TCCTCCTCCC TCTATCTTTC 540 CTCTTTCTTT CACGTCTCTC TCTCTATACC TCCTCAACTC CGGTCACCGT CTCCGGCGTT 600 TCCTCTGTTA TTCACCAGGC AGATGTCGGA GTCTTATACA CGATCTTGTT TCTCATCATC 660 GTCTTCACTT TAATCCACAG TCTCTCAGGA AAACCAGAAT GCTCTGTTCT CCATTCCCAT 720 CTCTACATCT GCTGGATCGT TCTCTTCATC GCCCAAGCTT GTGCCTTTGG GATCAAAAGA 780 ACCATGAGCA CGACCATGTC TATAAATCCA GACAAAAACT TGTTTCTTGC GACACATGAA 840 AGATGGATGT TGGTTAGGGT TTTGTTCTTT TTGGGGCTAC ACGAAGTGAT GCTGATGTGG 900 TTTAGAGTCG TGGTTAAGCC TGTGGTTGAC AACACTATAT ATGGGGTCTA CGTGGAGGAG 960 AGGTGGTCCG AGAGAGCCGT TGTGGCAGTG ACCTTTGGTA TAATGTGGTG GTGGAGGCTA 1020 AGAGATGAGG TAGAAAGTCT TGTGGTGGTG GTTACGGCGG ATAGACTTAA CCTCCCCATT 1080 CGTTTGGAGG GTCTCAATTT TGTGAACTGG TGTATGTATT ACATCTGTGT TGGAATTGGT 1140 TTAATGAAGA TCTTCAAAGG GTTTTTGGAT TTTGTGAATA CGTTGACTTT GAGCATTAAG 1200 AGGTCGAGAA AAGGCTGTGA ATCATGTGTT TTTGATGATA TGTGTAATGA TGATCATGTG 1260 TAAGATATTT GACATATTAT ACTCATCTCT TGAATGTTTT TGAGATTTTT TTATTTTTAT 1320 TTTCTATTTC TTGCTAGGAA TTTAACCCGT ATATATGTCA CAAAAATAGT AGAATATCAG 1380 AAAGCAAAAA TATTTTATCT AAAAATAACC ATTGAACATT AATTTAAGTC TTTTTATAAT 1440 TATATTTTTA TAACACACCC TTTTTAAGAA AAACTTGGAG ATTTAATTAA CGTTATAAAT 1500 AGTAAAAAAT ATCGGATTTA CGTAGAAGTT TTAAATGCGT ATAATTAAAT TTACGAATTG 1560 AATAATATAG CCATATATAT ATTTTTGAAG ATTTAAACTC ATTTTGTTTC TTCCATATAT 1620 GCATAATATA TAAGCTTAAA TAGAAAACTA GCTAGGAATG AATACTAATA TATATAATGA 1680 CATTAATATA AGTCTTACCG GACACTCCAA AATGTATATA TTGATCTATC AACATTTTTT 1740 CATTGGTTTA CTAAACCAAG TTGTCACATA AATATGAGTT AACGCCTTTT TTTTTATAAT 1800 ATTGTATATG AATTTAAACT TGAGCTGTCA AACGTCAAGC AAACCCAACA TCTACATACA 1860 TATAGTACTA TATTTTGAAA ATTAAAATTT TCTTAAATTT CCCATATTAT TTTCCTTTTA 1920 AAGCAAGCAA GTCCAAATAC GTTTCTTCCA GATTATAATT TTCCTTAATA AGGTTTTCTA 1980 CAAAAAAAAA TCAACTTCTT ATTTAAAAAA CCCTTTGCAT TATCCTTTTC ACCAACATCA 2040 GAGAAGACGA GAAAAAAAGA AGAGGCGAGT GGTTAATGGA GAAGGTTAGT TTCACTCCAA 2100 ACATATATGA ATTGACTAGG TTATGAAATC CATATATTTT AATTGTGTGT TTATGATAGA 2160 TCAATAACAT TTAGGGTTGA ATTTTCTTGT GATCTATTAT GTTATTCGTC CCATGCATGA 2220 TCCATAAAAC TTTTATTTTT GAATTTGTCT AGGAAAACCA TGAGGACGAT GGTGAGGGTT 2280 TGCCACCCGA ACTAAATCAG ATAAAAGAGC AAATCGAAAA GGAGAGATTT CTGCATATCA 2340 AGGTAAGAGA CATTTGGTTG CTTTAATATT TTATTCTCTT CTGTATGTTT TTCTGAAAAT 2400 TAAGGAGAGG AGAGGACTTA ATCTCATAAC TATACGATTC CAAAGAGATG TTAAGATACA 2460 TCTAATAAAC AGTTATACAT TAGTCATAAT CTTTAAAACT AAAAAGAGAA ATTTCCAAAC 2520 TTTTAAATTA AAAACAGAAT TTAGAAAATG CCAGCGAATC GATAACGACA TCCAGATCTG 2580 TCGGGTATCC AAAACTTAGA ATAAAAAAAT AATTAATATA TTTATAATAT AAAGCTGGAA 2640 CTTAGGTTAT AAAATAAAAT TGAAAATAAT AGTAGATTTT TTTGTTTTTG TCAAACAAAA 2700 TAGTAATACA ATTTGTTTTT TTTAGTACAA AGAAACTAAA TAGGTCCAAA TTGTTTTTTT 2760 TTTAACATTC AGCCAAAAAA GCCAAGATTG ATGCATATAT CAAGAAATCG AAATCAAAAC 2820 TTTTGTATTC AAGTATTCTA GTTTCACTAT ATATAGAGTC CAGTTTCTGA AATTTAAAAA 2880 ATCATTTACC TATATATTAC TTGATTAACA GAGAAAATTC GAGCTGAGAT ACATTCCAAG 2940 TGTGGCTACT CATGCTTCAC ACCATCAATC GTTTGACTTA AACCAGCCCG CTGCAGAGGA 3000 TGATAATGGA GGAGACAACA AATCACTTTT GTCGAGAATG CAAAACCCAC TTCGTCATTT 3060 CAGTGCCTCA TCTGATTATA ATTCTTACGA AGATCAAGGT TATGTTCTTG ATGAGGATCA 3120 AGATTATGCT CTTGAAGAAG ATGTACCATT ATTTCTTGAT GAAGATGTAC CATTATTACC 3180 AAGTGTCAAG CTTCCAATTG TTGAGAAGCT ACCACGATCC ATTACATGGG TCTTCACCAA 3240 AAGGCATGTG TGTTTTTTGT TTCGTACTAG TTTCAAAATA TTAATCATAT ACTATATAGT 3300 AATCACTCAT AGTGCATATA TACATTTCTT TAACATTGCA GTAGCCAGCT GATGGCTGAA 3360 AGTGATTCTG TGATTGGTAA GAGACAAATC TATTATTTGA ATGGTGAGGC ACTAGAATTG 3420 AGCAGTGAAG AAGATGAGGA AGATGAAGAA GAAGATGAGG AAGAAATCAA GAAAGAAAAA 3480 TGCGAATTTT CTGAAGATGT AGACCGATTT ATATGGTTAG TTTTTGCATT ACATATGTTC 3540 TTGATTATTA ATTTGTAGTC CATATTTAAT AAACTGCTCA AGAAATTTTC AGGACGGTTG 3600 GGCAGGACTA TGGTTTGGAT GATCTGGTCG TGCGGCGTGC TCTCGCCAAG TACCTCGAAG 3660 TGGATGTTTC GGACATATTG GTAACAATAT TCGAATAAAA ACTTCATACG TCGATCAATA 3720 ACTTTCCTGC TTATTTAATT TTTGTTGTTT TTCGTCGTGA GAAATGTTTT AAATTTTCAA 3780 ATCTAATGTA GGAAAGATAC AATGAACTCA AGCTTAAGAA TGATGGAACT GCTGGTGAGG 3840 CTTCTGATTT GACATCCAAG ACAATAACTA CTGCTTTCCA GGATTTTGCT GATAGACGTC 3900 ATTGCCGTCG TTGCATGGTA ACTTTGAATC TTTCTTTTTT AATTTAGCCA CAAAAAAGGG 3960 AGATGATCAT ACATGTTTTT ATTTTATTTT ATCATTTGTT TTACAGATAT TCGATTGTCA 4020 TATGCATGAG AAGTATGAGC CCGAGTCTAG ATCCGTAAGC ATTAAATTCA TTTAAATTAT 4080 TTTGTTAGTT TCACAACCCT TATATATAAG GTTAAGTGAT TAACTTAATT AGATTGCTTT 4140 GGCTTGTCAG AGCGAAGACA AATCTAGTTT GTTTGAGGAT GAAGATAGAC AACCATGCAG 4200 TGAGCATTGT TACCTCAAGG TCTCTATCTC TCTCCCTCTC TCTCTCAATT TTTTTGTCTA 4260 TTCCTTAATT ACGTTTATTA GTTACTGGTT TAATATTAAA TAGGTGAGGA GTGTGACAGA 4320 AGCTGATCAT GTGATGGATA ATGATAACTC TATATCAAAC AAGATTGTGG TCTCAGATCC 4380 AAACAACACT ATGTGGACGC CTGTAGAGAA GGATCTTTAC TTGAAAGGAA TTGAGATATT 4440 TGGGAGAAAC AGGTAAAAAA ATAAAAATAG ATTTAATGCA TTAATATATA TACTTACACT 4500 GTATTCCTTG ATTATGCTGG TTCGCAGTTG TGATGTTGCA TTAAACATAC TTCGGGGGCT 4560 TAAGACGTGC CTAGAGATTT ACAATTACAT GCGCGAACAA GATCAATGTA CTATGTCATT 4620 AGACCTTAAC AAAACTACAC AAAGACACAA TCAGGTACAC TAACCTATGT CGTAATTATT 4680 CTCATGACAT GTATGTTAAA AACACATGAA GTTTCCTATA TGTGTTGATG GTTTTATCAC 4740 AGGTTACCAA AAAAGTATCT CGAAAAAGTA GTAGGTCGGT CCGCAAAAAA TCGAGACTCC 4800 GAAAATATGC TCGTTATCCG CCTGCTTTAA AGAAAACAAC TAGTGGAGAA GCTAAGTTTT 4860 ATAAGCACTA CACACCATGC ACTTGCAAGT CAAAATGTGG ACAGCAATGC CCTTGTTTAA 4920 CTCACGAAAA TTGCTGCGAG AAATATTGCG GGTATGTCAT TCAATTTTTC CTAAGCCGGA 4980 AGATCCATGA GATTTAATTT GAACATGAGT TTGTATTTTT TGTTCAGGTG CTCAAAGGAT 5040 TGCAACAATC GCTTTGGAGG ATGTAATTGT GCAATTGGCC AATGCACAAA TCGACAATGT 5100 CCTTGTTTTG CTGCTAATCG TGAATGCGAT CCAGATCTTT GTCGGAGTTG TCCTCTTAGG 5160 TAACACTTTC ACTTCAATAT CTCTTTATAC AAATTCTATA ATCAAAGTAA TTCAAACCAA 5220 AAGTCTTATA AAAAAAACTT TATATATAGC TGTGGAGATG GCACTCTTGG TGAGACACCA 5280 GTGCAAATCC AATGCAAGAA CATGCAATTC CTCCTTCAAA CCAATAAAAA GGTAATCAAC 5340 GTCAAATCCG TACCGAAAAT TTAAAACTAA TTATACGAAA GACATTTAAC TATCATTTCC 5400 CGTATTTTAC TAGATTCTCA TTGGAAAGTC TGATGTTCAT GGATGGGGTG CATTTACATG 5460 GGTAAGCAAT CATGTAAATA TAAGAATAAG TTTAATAGTT ATTGGTGCAT TCATAACACT 5520 TTTTTTTTTT TAATAATGTT TTATACTTTA GACCATTAAA TATATTGTGT GATATGGTTT 5580 GACCCGTCAG GACTCTCTTA AAAAGAATGA GTATCTCGGA GAATATACTG GAGAACTGAT 5640 CACTCATGAT GAAGCTAATG AGCGTGGGAG AATAGAAGAT CGGATTGGTT CTTCCTACCT 5700 CTTTACCTTG AATGATCAGG TAACTTCAGA ATAATTTTGA AGTAACGTTT TAATCATTCG 5760 CGGGTTACAC ATCTATTCGA ATCAAAGTAA CATTTATTTT ACAGCTCGAA ATCGATGCTC 5820 GCCGTAAAGG AAACGAGTTC AAATTTCTCA ATCACTCAGC AAGACCTAAC TGCTACGCCA 5880 AGGTACTAAG CCGTTATACT TTATCTTGAA CAAATACTAA CATTATACAA ACAAAAATAC 5940 TTATGTTAGT TTCTTTAGTT AAATCGTGTA TCAACTTTAC TCGTCGTTGA TTGGTTTTCA 6000 TATTGAAGAT ATTCCAAGAA ACTCAAACTC ATTTTAAATG ATTTTTTCTT GTCGAGAAAA 6060 TTTAGGTTAC GAAAATTTAT GGTTTCGTGT GCAGTTGATG ATTGTGAGAG GAGATCAGAG 6120 GATTGGTCTA TTTGCGGAGA GAGCAATCGA AGAAGGTGAG GAGCTTTTCT TCGACTACTG 6180 CTATGGACCA GAACATGCGG ATTGGTCGCG TGGTCGAGAA CCTAGAAAGA CTGGTGCTTC 6240 TAAAAGGTCT AAGGAAGCCC GTCCAGCTCG TTAGTTTTTG ATCTGAGGAG AAGCAGCAAT 6300 TCAAGCAGTC CTTTTTTTAT GTTATGGTAT ATCAATTAAT AATGTAATGC TATTTTGTGT 6360 TACTAAACCA AAACTTAAGT TTCTGTTTTA TTTGTTTTAG GGTGTTTTGT TTGTATCATA 6420 TGTGTCTTAA CTTTCAAAGT TTTCTTTTTG TATTTCAATT TAAAAACAAT GTTTATGTTG 6480 TTAGTTTGCA TAGACCTTTG GAAAAAAAAA GCTTTGCACA ACTTTACATT TATTTAGTCT 6540 TCATTTAGCG AAAAATCACA TAACACAAGT CTGTGGTACG TAATGTACAA AAATGTCAAA 6600 ATAATGGGTT TTATCATTAA AAAAAAATAT TGGTTATGAA TGAAGTATAG TTAGAATTTT 6660 AGGTATTAGC TCGTTTGGTT TTAAAACGTT TTTCGAGATT TAATTTTGTA GTCTATTGAG 6720 TAATACATGG AAGAATCATC AACAAAGTGG CTGTAGCTTA CGAAAGGTTT TACTTTAATG 6780 TAAATATGTA TTTGATGCAT CTAACATTTA GTATCTAAAC AAATAAAAAC AAAAAAAAAG 6840 AAAAAAGCTC TTTAAAATCC GAAAGTAACT ATTTTCAAAA AATCTAAATT ATAAACTTAA 6900 ATGTTTGGAA TCGCGAACGA CTATTGCTAA ATATAAATGC TAAATATACA TGAAGATGTG 6960 AAAAACATGT TGGATTTGTG GAATCGTTAA TGACCACGGT TAAATGGCGG GATCC 7015 34 amino acids amino acid linear peptide 7 Gly Ser Ile Ile Phe Lys Asn Gln Ile Phe Ser Tyr Leu Leu Phe Val 1 5 10 15 Ser Lys Lys Lys Lys Thr His Asp Asp Tyr Pro Ser Ala Gly Cys Val 20 25 30 His Arg 12 amino acids amino acid linear peptide 8 Thr Tyr Ile Leu Lys Leu Val Gly Phe Ser Leu Pro 1 5 10 18 amino acids amino acid linear peptide 9 Val Trp Thr Cys Phe Tyr Asn Leu Met Tyr Ser Val Asp Gln Lys Ile 1 5 10 15 Glu Lys 6 amino acids amino acid linear peptide 10 Glu Arg Glu Pro Leu Trp 1 5 20 amino acids amino acid linear peptide 11 Gln Asn Arg Asn His Tyr Ile Glu Ser Phe Glu Lys Thr Lys Arg Ser 1 5 10 15 Asn Leu Cys Ser 20 15 amino acids amino acid linear peptide 12 Met Thr Ile Asp Val Ala Ala Asn Tyr Ser Leu Asn Ala Phe Ile 1 5 10 15 307 amino acids amino acid linear peptide 13 Ile Phe Leu Thr Ser Ser Val Pro Ser His Ser Arg Asn Ser Ile Ile 1 5 10 15 Pro Phe Ser Phe Phe Phe Ser Val Phe Gln Ser Leu Arg Ile Lys Met 20 25 30 Glu His Glu Glu Thr Gln Lys Asn Thr Arg Asn Ser Trp Ser Leu Ile 35 40 45 Arg Pro Phe Gln Met Ile Ser Ile Ser Phe Leu Ser Leu Leu Leu Pro 50 55 60 Leu Ser Phe Leu Phe Leu Ser Arg Leu Ser Leu Tyr Thr Ser Ser Thr 65 70 75 80 Pro Val Thr Val Ser Gly Val Ser Ser Val Ile His Gln Ala Asp Val 85 90 95 Gly Val Leu Tyr Thr Ile Leu Phe Leu Ile Ile Val Phe Thr Leu Ile 100 105 110 His Ser Leu Ser Gly Lys Pro Glu Cys Ser Val Leu His Ser His Leu 115 120 125 Tyr Ile Cys Trp Ile Val Leu Phe Ile Ala Gln Ala Cys Ala Phe Gly 130 135 140 Ile Lys Arg Thr Met Ser Thr Thr Met Ser Ile Asn Pro Asp Lys Asn 145 150 155 160 Leu Phe Leu Ala Thr His Glu Arg Trp Met Leu Val Arg Val Leu Phe 165 170 175 Phe Leu Gly Leu His Glu Val Met Leu Met Trp Phe Arg Val Val Val 180 185 190 Lys Pro Val Val Asp Asn Thr Ile Tyr Gly Val Tyr Val Glu Glu Arg 195 200 205 Trp Ser Glu Arg Ala Val Val Ala Val Thr Phe Gly Ile Met Trp Trp 210 215 220 Trp Arg Leu Arg Asp Glu Val Glu Ser Leu Val Val Val Val Thr Ala 225 230 235 240 Asp Arg Leu Asn Leu Pro Ile Arg Leu Glu Gly Leu Asn Phe Val Asn 245 250 255 Trp Cys Met Tyr Tyr Ile Cys Val Gly Ile Gly Leu Met Lys Ile Phe 260 265 270 Lys Gly Phe Leu Asp Phe Val Asn Thr Leu Thr Leu Ser Ile Lys Arg 275 280 285 Ser Arg Lys Gly Cys Glu Ser Cys Val Phe Asp Asp Met Cys Asn Asp 290 295 300 Asp His Val 305 6 amino acids amino acid linear peptide 14 His Ile Ile Leu Ile Ser 1 5 42 amino acids amino acid linear peptide 15 Met Phe Leu Arg Phe Phe Tyr Phe Tyr Phe Leu Phe Leu Ala Arg Asn 1 5 10 15 Leu Thr Arg Ile Tyr Val Thr Lys Ile Val Glu Tyr Gln Lys Ala Lys 20 25 30 Ile Phe Tyr Leu Lys Ile Thr Ile Glu His 35 40 14 amino acids amino acid linear peptide 16 Phe Lys Ser Phe Tyr Asn Tyr Ile Phe Ile Thr His Pro Phe 1 5 10 26 amino acids amino acid linear peptide 17 Glu Lys Leu Gly Asp Leu Ile Asn Val Ile Asn Ser Lys Lys Tyr Arg 1 5 10 15 Ile Tyr Val Glu Val Leu Asn Ala Tyr Asn 20 25 15 amino acids amino acid linear peptide 18 Ile Tyr Glu Leu Asn Asn Ile Ala Ile Tyr Ile Phe Leu Lys Ile 1 5 10 15 9 amino acids amino acid linear peptide 19 Thr His Phe Val Ser Ser Ile Tyr Ala 1 5 13 amino acids amino acid linear peptide 20 Tyr Ile Ser Leu Asn Arg Lys Leu Ala Arg Asn Glu Tyr 1 5 10 31 amino acids amino acid linear peptide 21 Tyr Lys Ser Tyr Arg Thr Leu Gln Asn Val Tyr Ile Asp Leu Ser Thr 1 5 10 15 Phe Phe His Trp Phe Thr Lys Pro Ser Cys His Ile Asn Met Ser 20 25 30 31 amino acids amino acid linear peptide 22 Arg Leu Phe Phe Tyr Asn Ile Val Tyr Glu Phe Lys Leu Glu Leu Ser 1 5 10 15 Asn Val Lys Gln Thr Gln His Leu His Thr Tyr Ser Thr Ile Phe 20 25 30 5 amino acids amino acid linear peptide 23 Lys Leu Lys Phe Ser 1 5 23 amino acids amino acid linear peptide 24 Ile Ser His Ile Ile Phe Leu Leu Lys Gln Ala Ser Pro Asn Thr Phe 1 5 10 15 Leu Pro Asp Tyr Asn Phe Pro 20 34 amino acids amino acid linear peptide 25 Gly Phe Leu Gln Lys Lys Ile Asn Phe Leu Phe Lys Lys Pro Phe Ala 1 5 10 15 Leu Ser Phe Ser Pro Thr Ser Glu Lys Thr Arg Lys Lys Glu Glu Ala 20 25 30 Ser Gly 12 amino acids amino acid linear peptide 26 Trp Arg Arg Leu Val Ser Leu Gln Thr Tyr Met Asn 1 5 10 8 amino acids amino acid linear peptide 27 Leu Gly Tyr Glu Ile His Ile Phe 1 5 25 amino acids amino acid linear peptide 28 Leu Cys Val Tyr Asp Arg Ser Ile Thr Phe Arg Val Glu Phe Ser Cys 1 5 10 15 Asp Leu Leu Cys Tyr Ser Ser His Ala 20 25 24 amino acids amino acid linear peptide 29 Ser Ile Lys Leu Leu Phe Leu Asn Leu Ser Arg Lys Thr Met Arg Thr 1 5 10 15 Met Val Arg Val Cys His Pro Asn 20 13 amino acids amino acid linear peptide 30 Lys Ser Lys Ser Lys Arg Arg Asp Phe Cys Ile Ser Arg 1 5 10 18 amino acids amino acid linear peptide 31 Glu Thr Phe Gly Cys Phe Asn Ile Leu Phe Ser Ser Val Cys Phe Ser 1 5 10 15 Glu Asn 5 amino acids amino acid linear peptide 32 Gly Glu Glu Arg Thr 1 5 10 amino acids amino acid linear peptide 33 Ser His Asn Tyr Thr Ile Pro Lys Arg Cys 1 5 10 13 amino acids amino acid linear peptide 34 Asp Thr Ser Asn Lys Gln Leu Tyr Ile Ser His Asn Leu 1 5 10 7 amino acids amino acid linear peptide 35 Lys Glu Lys Phe Pro Asn Phe 1 5 5 amino acids amino acid linear peptide 36 Ile Lys Asn Arg Ile 1 5 6 amino acids amino acid linear peptide 37 Lys Met Pro Ala Asn Arg 1 5 12 amino acids amino acid linear peptide 38 Arg His Pro Asp Leu Ser Gly Ile Gln Asn Leu Glu 1 5 10 11 amino acids amino acid linear peptide 39 Tyr Ile Tyr Asn Ile Lys Leu Glu Leu Arg Leu 1 5 10 16 amino acids amino acid linear peptide 40 Asn Lys Ile Glu Asn Asn Ser Arg Phe Phe Cys Phe Cys Gln Thr Lys 1 5 10 15 10 amino acids amino acid linear peptide 41 Tyr Asn Leu Phe Phe Leu Val Gln Arg Asn 1 5 10 33 amino acids amino acid linear peptide 42 Ile Gly Pro Asn Cys Phe Phe Phe Asn Ile Gln Pro Lys Lys Pro Arg 1 5 10 15 Leu Met His Ile Ser Arg Asn Arg Asn Gln Asn Phe Cys Ile Gln Val 20 25 30 Phe 4 amino acids amino acid linear peptide 43 Phe His Tyr Ile 1 6 amino acids amino acid linear peptide 44 Ser Pro Val Ser Glu Ile 1 5 8 amino acids amino acid linear peptide 45 Lys Ile Ile Tyr Leu Tyr Ile Thr 1 5 23 amino acids amino acid linear peptide 46 Leu Thr Glu Lys Ile Arg Ala Glu Ile His Ser Lys Cys Gly Tyr Ser 1 5 10 15 Cys Phe Thr Pro Ser Ile Val 20 8 amino acids amino acid linear peptide 47 Leu Lys Pro Ala Arg Cys Arg Gly 1 5 22 amino acids amino acid linear peptide 48 Trp Arg Arg Gln Gln Ile Thr Phe Val Glu Asn Ala Lys Pro Thr Ser 1 5 10 15 Ser Phe Gln Cys Leu Ile 20 9 amino acids amino acid linear peptide 49 Phe Leu Arg Arg Ser Arg Leu Cys Ser 1 5 6 amino acids amino acid linear peptide 50 Gly Ser Arg Leu Cys Ser 1 5 7 amino acids amino acid linear peptide 51 Arg Arg Cys Thr Ile Ile Ser 1 5 13 amino acids amino acid linear peptide 52 Arg Cys Thr Ile Ile Thr Lys Cys Gln Ala Ser Asn Cys 1 5 10 21 amino acids amino acid linear peptide 53 Glu Ala Thr Thr Ile His Tyr Met Gly Leu His Gln Lys Ala Cys Val 1 5 10 15 Phe Phe Val Ser Tyr 20 13 amino acids amino acid linear peptide 54 Phe Gln Asn Ile Asn His Ile Leu Tyr Ser Asn His Ser 1 5 10 6 amino acids amino acid linear peptide 55 Cys Ile Tyr Thr Phe Leu 1 5 74 amino acids amino acid linear peptide 56 His Cys Ser Ser Gln Leu Met Ala Glu Ser Asp Ser Val Ile Gly Lys 1 5 10 15 Arg Gln Ile Tyr Tyr Leu Asn Gly Glu Ala Leu Glu Leu Ser Ser Glu 20 25 30 Glu Asp Glu Glu Asp Glu Glu Glu Asp Glu Glu Glu Ile Lys Lys Glu 35 40 45 Lys Cys Glu Phe Ser Glu Asp Val Asp Arg Phe Ile Trp Leu Val Phe 50 55 60 Ala Leu His Met Phe Leu Ile Ile Asn Leu 65 70 41 amino acids amino acid linear peptide 57 Ser Ile Phe Asn Lys Leu Leu Lys Lys Phe Ser Gly Arg Leu Gly Arg 1 5 10 15 Thr Met Val Trp Met Ile Trp Ser Cys Gly Val Leu Ser Pro Ser Thr 20 25 30 Ser Lys Trp Met Phe Arg Thr Tyr Trp 35 40 17 amino acids amino acid linear peptide 58 Gln Tyr Ser Asn Lys Asn Phe Ile Arg Arg Ser Ile Thr Phe Leu Leu 1 5 10 15 Ile 15 amino acids amino acid linear peptide 59 Phe Leu Leu Phe Phe Val Val Arg Asn Val Leu Asn Phe Gln Ile 1 5 10 15 21 amino acids amino acid linear peptide 60 Cys Arg Lys Asp Thr Met Asn Ser Ser Leu Arg Met Met Glu Leu Leu 1 5 10 15 Val Arg Leu Leu Ile 20 4 amino acids amino acid linear peptide 61 His Pro Arg Gln 1 17 amino acids amino acid linear peptide 62 Leu Leu Leu Ser Arg Ile Leu Leu Ile Asp Val Ile Ala Val Val Ala 1 5 10 15 Trp 4 amino acids amino acid linear peptide 63 Ile Phe Leu Phe 1 7 amino acids amino acid linear peptide 64 Phe Ser His Lys Lys Gly Arg 1 5 20 amino acids amino acid linear peptide 65 Ser Tyr Met Phe Leu Phe Tyr Phe Ile Ile Cys Phe Thr Asp Ile Arg 1 5 10 15 Leu Ser Tyr Ala 20 4 amino acids amino acid linear peptide 66 Ile Arg Lys His 1 17 amino acids amino acid linear peptide 67 Ile His Leu Asn Tyr Phe Val Ser Phe Thr Thr Leu Ile Tyr Lys Val 1 5 10 15 Lys 12 amino acids amino acid linear peptide 68 Leu Asp Cys Phe Gly Leu Ser Glu Arg Arg Gln Ile 1 5 10 4 amino acids amino acid linear peptide 69 Thr Thr Met Gln 1 25 amino acids amino acid linear peptide 70 Ala Leu Leu Pro Gln Gly Leu Tyr Leu Ser Pro Ser Leu Ser Gln Phe 1 5 10 15 Phe Cys Leu Phe Leu Asn Tyr Val Tyr 20 25 8 amino acids amino acid linear peptide 71 Ile Gly Glu Glu Cys Asp Arg Ser 1 5 4 amino acids amino acid linear peptide 72 Ser Cys Asp Gly 1 28 amino acids amino acid linear peptide 73 Leu Tyr Ile Lys Gln Asp Cys Gly Leu Arg Ser Lys Gln His Tyr Val 1 5 10 15 Asp Ala Cys Arg Glu Gly Ser Leu Leu Glu Arg Asn 20 25 9 amino acids amino acid linear peptide 74 Asp Ile Trp Glu Lys Gln Val Lys Lys 1 5 18 amino acids amino acid linear peptide 75 Cys Ile Asn Ile Tyr Thr Tyr Thr Val Phe Leu Asp Tyr Ala Gly Ser 1 5 10 15 Gln Leu 9 amino acids amino acid linear peptide 76 Cys Cys Ile Lys His Thr Ser Gly Ala 1 5 21 amino acids amino acid linear peptide 77 Asp Val Pro Arg Asp Leu Gln Leu His Ala Arg Thr Arg Ser Met Tyr 1 5 10 15 Tyr Val Ile Arg Pro 20 32 amino acids amino acid linear peptide 78 Gln Asn Tyr Thr Lys Thr Gln Ser Gly Thr Leu Thr Tyr Val Val Ile 1 5 10 15 Ile Leu Met Thr Cys Met Leu Lys Thr His Glu Val Ser Tyr Met Cys 20 25 30 33 amino acids amino acid linear peptide 79 Trp Phe Tyr His Arg Leu Pro Lys Lys Tyr Leu Glu Lys Val Val Gly 1 5 10 15 Arg Ser Ala Lys Asn Arg Asp Ser Glu Asn Met Leu Val Ile Arg Leu 20 25 30 Leu 29 amino acids amino acid linear peptide 80 Arg Lys Gln Leu Val Glu Lys Leu Ser Phe Ile Ser Thr Thr His His 1 5 10 15 Ala Leu Ala Ser Gln Asn Val Asp Ser Asn Ala Leu Val 20 25 17 amino acids amino acid linear peptide 81 Leu Thr Lys Ile Ala Ala Arg Asn Ile Ala Gly Met Ser Phe Asn Phe 1 5 10 15 Ser 62 amino acids amino acid linear peptide 82 Ala Gly Arg Ser Met Arg Phe Asn Leu Asn Met Ser Leu Tyr Phe Leu 1 5 10 15 Phe Arg Cys Ser Lys Asp Cys Asn Asn Arg Phe Gly Gly Cys Asn Cys 20 25 30 Ala Ile Gly Gln Cys Thr Asn Arg Gln Cys Pro Cys Phe Ala Ala Asn 35 40 45 Arg Glu Cys Asp Pro Asp Leu Cys Arg Ser Cys Pro Leu Arg 50 55 60 66 amino acids amino acid linear peptide 83 His Phe His Phe Asn Ile Ser Leu Tyr Lys Phe Tyr Asn Gln Ser Asn 1 5 10 15 Ser Asn Gln Lys Ser Tyr Lys Lys Asn Phe Ile Tyr Ser Cys Gly Asp 20 25 30 Gly Thr Leu Gly Glu Thr Pro Val Gln Ile Gln Cys Lys Asn Met Gln 35 40 45 Phe Leu Leu Gln Thr Asn Lys Lys Val Ile Asn Val Lys Ser Val Pro 50 55 60 Lys Ile 65 20 amino acids amino acid linear peptide 84 Leu Tyr Glu Arg His Leu Thr Ile Ile Ser Arg Ile Leu Leu Asp Ser 1 5 10 15 His Trp Lys Val 20 41 amino acids amino acid linear peptide 85 Cys Ser Trp Met Gly Cys Ile Tyr Met Gly Lys Gln Ser Cys Lys Tyr 1 5 10 15 Lys Asn Lys Phe Asn Ser Tyr Trp Cys Ile His Asn Thr Phe Phe Phe 20 25 30 Leu Ile Met Phe Tyr Thr Leu Asp His 35 40 13 amino acids amino acid linear peptide 86 Ile Tyr Cys Val Ile Trp Phe Asp Pro Ser Gly Leu Ser 1 5 10 12 amino acids amino acid linear peptide 87 Val Ser Arg Arg Ile Tyr Trp Arg Thr Asp His Ser 1 5 10 17 amino acids amino acid linear peptide 88 Ala Trp Glu Asn Arg Arg Ser Asp Trp Phe Phe Leu Pro Leu Tyr Leu 1 5 10 15 Glu 9 amino acids amino acid linear peptide 89 Ser Gly Asn Phe Arg Ile Ile Leu Lys 1 5 14 amino acids amino acid linear peptide 90 Arg Phe Asn His Ser Arg Val Thr His Leu Phe Glu Ser Lys 1 5 10 32 amino acids amino acid linear peptide 91 His Leu Phe Tyr Ser Ser Lys Ser Met Leu Ala Val Lys Glu Thr Ser 1 5 10 15 Ser Asn Phe Ser Ile Thr Gln Gln Asp Leu Thr Ala Thr Pro Arg Tyr 20 25 30 19 amino acids amino acid linear peptide 92 Ala Val Ile Leu Tyr Leu Glu Gln Ile Leu Thr Leu Tyr Lys Gln Lys 1 5 10 15 Tyr Leu Cys 15 amino acids amino acid linear peptide 93 Leu Asn Arg Val Ser Thr Leu Leu Val Val Asp Trp Phe Ser Tyr 1 5 10 15 50 amino acids amino acid linear peptide 94 Arg Tyr Ser Lys Lys Leu Lys Leu Ile Leu Asn Asp Phe Phe Leu Ser 1 5 10 15 Arg Lys Phe Arg Leu Arg Lys Phe Met Val Ser Cys Ala Val Asp Asp 20 25 30 Cys Glu Arg Arg Ser Glu Asp Trp Ser Ile Cys Gly Glu Ser Asn Arg 35 40 45 Arg Arg 50 21 amino acids amino acid linear peptide 95 Gly Ala Phe Leu Arg Leu Leu Leu Trp Thr Arg Thr Cys Gly Leu Val 1 5 10 15 Ala Trp Ser Arg Thr 20 5 amino acids amino acid linear peptide 96 Lys Asp Trp Cys Phe 1 5 28 amino acids amino acid linear peptide 97 Gly Ser Pro Ser Ser Ser Leu Val Phe Asp Leu Arg Arg Ser Ser Asn 1 5 10 15 Ser Ser Ser Pro Phe Phe Met Leu Trp Tyr Ile Asn 20 25 7 amino acids amino acid linear peptide 98 Cys Asn Ala Ile Leu Cys Tyr 1 5 52 amino acids amino acid linear peptide 99 Val Ser Val Leu Phe Val Leu Gly Cys Phe Val Cys Ile Ile Cys Val 1 5 10 15 Leu Thr Phe Lys Val Phe Phe Leu Tyr Phe Asn Leu Lys Thr Met Phe 20 25 30 Met Leu Leu Val Cys Ile Asp Leu Trp Lys Lys Lys Ala Leu His Asn 35 40 45 Phe Thr Phe Ile 50 33 amino acids amino acid linear peptide 100 Ser Ser Phe Ser Glu Lys Ser His Asn Thr Ser Leu Trp Tyr Val Met 1 5 10 15 Tyr Lys Asn Val Lys Ile Met Gly Phe Ile Ile Lys Lys Lys Tyr Trp 20 25 30 Leu 4 amino acids amino acid linear peptide 101 Met Lys Tyr Ser 1 4 amino acids amino acid linear peptide 102 Asn Phe Arg Tyr 1 4 amino acids amino acid linear peptide 103 Leu Val Trp Phe 1 8 amino acids amino acid linear peptide 104 Asn Val Phe Arg Asp Leu Ile Leu 1 5 10 amino acids amino acid linear peptide 105 Tyr Met Glu Glu Ser Ser Thr Lys Trp Leu 1 5 10 8 amino acids amino acid linear peptide 106 Leu Thr Lys Gly Phe Thr Leu Met 1 5 16 amino acids amino acid linear peptide 107 His Leu Val Ser Lys Gln Ile Lys Thr Lys Lys Lys Lys Lys Ala Leu 1 5 10 15 12 amino acids amino acid linear peptide 108 Asn Pro Lys Val Thr Ile Phe Lys Lys Ser Lys Leu 1 5 10 9 amino acids amino acid linear peptide 109 Met Phe Gly Ile Ala Asn Asp Tyr Cys 1 5 17 amino acids amino acid linear peptide 110 Met Leu Asn Ile His Glu Asp Val Lys Asn Met Leu Asp Leu Trp Asn 1 5 10 15 Arg 7 amino acids amino acid linear peptide 111 Pro Arg Leu Asn Gly Gly Ile 1 5 38 amino acids amino acid linear peptide 112 Asp Pro Leu Phe Leu Lys Ile Lys Phe Phe His Ile Tyr Tyr Leu Phe 1 5 10 15 Gln Arg Lys Lys Lys His Thr Thr Ile Ile His Leu Pro Ala Val Phe 20 25 30 Ile Gly Lys Pro Ile Phe 35 16 amino acids amino acid linear peptide 113 Asn Trp Trp Ala Phe His Tyr His Lys Phe Gly His Val Phe Ile Ile 1 5 10 15 33 amino acids amino acid linear peptide 114 Arg Asn Lys Lys Gly Asn Leu Cys Gly Asp Cys Asn Lys Thr Glu Ile 1 5 10 15 Ile Ile Leu Asn His Ser Lys Arg Arg Lys Asp Gln Thr Phe Val Ala 20 25 30 Arg 59 amino acids amino acid linear peptide 115 Thr Trp Leu Pro Ile Thr Val Leu Met Leu Leu Tyr Arg Ser Phe Leu 1 5 10 15 His Pro Leu Phe Leu His Ile Gln Glu Thr Val Ser Ser His Phe Leu 20 25 30 Ser Ser Ser Gln Cys Phe Asn Leu Cys Glu Leu Arg Trp Asn Met Lys 35 40 45 Lys His Lys Arg Thr Gln Glu Thr Ala Gly Pro 50 55 5 amino acids amino acid linear peptide 116 Phe Asp His Phe Lys 1 5 57 amino acids amino acid linear peptide 117 Ser Pro Leu Ala Phe Leu Ala Ser Ser Ser Leu Tyr Leu Ser Ser Phe 1 5 10 15 Phe His Val Ser Leu Ser Ile Pro Pro Gln Leu Arg Ser Pro Ser Pro 20 25 30 Ala Phe Pro Leu Leu Phe Thr Arg Gln Met Ser Glu Ser Tyr Thr Arg 35 40 45 Ser Cys Phe Ser Ser Ser Ser Ser Leu 50 55 37 amino acids amino acid linear peptide 118 Ser Thr Val Ser Gln Glu Asn Gln Asn Ala Leu Phe Ser Ile Pro Ile 1 5 10 15 Ser Thr Ser Ala Gly Ser Phe Ser Ser Ser Pro Lys Leu Val Pro Leu 20 25 30 Gly Ser Lys Glu Pro 35 5 amino acids amino acid linear peptide 119 Ala Arg Pro Cys Leu 1 5 27 amino acids amino acid linear peptide 120 Ile Gln Thr Lys Thr Cys Phe Leu Arg His Met Lys Asp Gly Cys Trp 1 5 10 15 Leu Gly Phe Cys Ser Phe Trp Gly Tyr Thr Lys 20 25 31 amino acids amino acid linear peptide 121 Cys Gly Leu Glu Ser Trp Leu Ser Leu Trp Leu Thr Thr Leu Tyr Met 1 5 10 15 Gly Ser Thr Trp Arg Arg Gly Gly Pro Arg Glu Pro Leu Trp Gln 20 25 30 5 amino acids amino acid linear peptide 122 Cys Gly Gly Gly Gly 1 5 23 amino acids amino acid linear peptide 123 Lys Val Leu Trp Trp Trp Leu Arg Arg Ile Asp Leu Thr Ser Pro Phe 1 5 10 15 Val Trp Arg Val Ser Ile Leu 20 12 amino acids amino acid linear peptide 124 Thr Gly Val Cys Ile Thr Ser Val Leu Glu Leu Val 1 5 10 9 amino acids amino acid linear peptide 125 Arg Ser Ser Lys Gly Phe Trp Ile Leu 1 5 36 amino acids amino acid linear peptide 126 Ala Leu Arg Gly Arg Glu Lys Ala Val Asn His Val Phe Leu Met Ile 1 5 10 15 Cys Val Met Met Ile Met Cys Lys Ile Phe Asp Ile Leu Tyr Ser Ser 20 25 30 Leu Glu Cys Phe 35 13 amino acids amino acid linear peptide 127 Asp Phe Phe Ile Phe Ile Phe Tyr Phe Leu Leu Gly Ile 1 5 10 7 amino acids amino acid linear peptide 128 Pro Val Tyr Met Ser Gln Lys 1 5 9 amino acids amino acid linear peptide 129 Asn Ile Arg Lys Gln Lys Tyr Phe Ile 1 5 14 amino acids amino acid linear peptide 130 Pro Leu Asn Ile Asn Leu Ser Leu Phe Ile Ile Ile Phe Leu 1 5 10 10 amino acids amino acid linear peptide 131 His Thr Leu Phe Lys Lys Asn Leu Glu Ile 1 5 10 8 amino acids amino acid linear peptide 132 Ile Val Lys Asn Ile Gly Phe Thr 1 5 8 amino acids amino acid linear peptide 133 Met Arg Ile Ile Lys Phe Thr Asn 1 5 5 amino acids amino acid linear peptide 134 Pro Tyr Ile Tyr Phe 1 5 14 amino acids amino acid linear peptide 135 Arg Phe Lys Leu Ile Leu Phe Leu Pro Tyr Met His Asn Ile 1 5 10 39 amino acids amino acid linear peptide 136 Leu Gly Met Asn Thr Asn Ile Tyr Asn Asp Ile Asn Ile Ser Leu Thr 1 5 10 15 Gly His Ser Lys Met Tyr Ile Leu Ile Tyr Gln His Phe Phe Ile Gly 20 25 30 Leu Leu Asn Gln Val Val Thr 35 35 amino acids amino acid linear peptide 137 Val Asn Ala Phe Phe Phe Ile Ile Leu Tyr Met Asn Leu Asn Leu Ser 1 5 10 15 Cys Gln Thr Ser Ser Lys Pro Asn Ile Tyr Ile His Ile Val Leu Tyr 20 25 30 Phe Glu Asn 35 11 amino acids amino acid linear peptide 138 Asn Phe Leu Lys Phe Pro Ile Leu Phe Ser Phe 1 5 10 55 amino acids amino acid linear peptide 139 Ser Lys Gln Val Gln Ile Arg Phe Phe Gln Ile Ile Ile Phe Leu Asn 1 5 10 15 Lys Val Phe Tyr Lys Lys Lys Ser Thr Ser Tyr Leu Lys Asn Pro Leu 20 25 30 His Tyr Pro Phe His Gln His Gln Arg Arg Arg Glu Lys Lys Lys Arg 35 40 45 Arg Val Val Asn Gly Glu Gly 50 55 6 amino acids amino acid linear peptide 140 Phe His Ser Lys His Ile 1 5 15 amino acids amino acid linear peptide 141 Val Met Lys Ser Ile Tyr Phe Asn Cys Val Phe Met Ile Asp Gln 1 5 10 15 19 amino acids amino acid linear peptide 142 His Leu Gly Leu Asn Phe Leu Val Ile Tyr Tyr Val Ile Arg Pro Met 1 5 10 15 His Asp Pro 4 amino acids amino acid linear peptide 143 Asn Phe Tyr Phe 1 6 amino acids amino acid linear peptide 144 Ile Cys Leu Gly Lys Pro 1 5 107 amino acids amino acid linear peptide 145 Gly Phe Ala Thr Arg Thr Lys Ser Asp Lys Arg Ala Asn Arg Lys Gly 1 5 10 15 Glu Ile Ser Ala Tyr Gln Gly Lys Arg His Leu Val Ala Leu Ile Phe 20 25 30 Tyr Ser Leu Leu Tyr Val Phe Leu Lys Ile Lys Glu Arg Arg Gly Leu 35 40 45 Asn Leu Ile Thr Ile Arg Phe Gln Arg Asp Val Lys Ile His Leu Ile 50 55 60 Asn Ser Tyr Thr Leu Val Ile Ile Phe Lys Thr Lys Lys Arg Asn Phe 65 70 75 80 Gln Thr Phe Lys Leu Lys Thr Glu Phe Arg Lys Cys Gln Arg Ile Asp 85 90 95 Asn Asp Ile Gln Ile Cys Arg Val Ser Lys Thr 100 105 10 amino acids amino acid linear peptide 146 Asn Lys Lys Ile Ile Asn Ile Phe Ile Ile 1 5 10 30 amino acids amino acid linear peptide 147 Ser Trp Asn Leu Gly Tyr Lys Ile Lys Leu Lys Ile Ile Val Asp Phe 1 5 10 15 Phe Val Phe Val Lys Gln Asn Ser Asn Thr Ile Cys Phe Phe 20 25 30 5 amino acids amino acid linear peptide 148 Tyr Lys Glu Thr Lys 1 5 15 amino acids amino acid linear peptide 149 Val Gln Ile Val Phe Phe Leu Thr Phe Ser Gln Lys Ser Gln Asp 1 5 10 15 38 amino acids amino acid linear peptide 150 Cys Ile Tyr Gln Glu Ile Glu Ile Lys Thr Phe Val Phe Lys Tyr Ser 1 5 10 15 Ser Phe Thr Ile Tyr Arg Val Gln Phe Leu Lys Phe Lys Lys Ser Phe 20 25 30 Thr Tyr Ile Leu Leu Asp 35 147 amino acids amino acid linear peptide 151 Gln Arg Lys Phe Glu Leu Arg Tyr Ile Pro Ser Val Ala Thr His Ala 1 5 10 15 Ser His His Gln Ser Phe Asp Leu Asn Gln Pro Ala Ala Glu Asp Asp 20 25 30 Asn Gly Gly Asp Asn Lys Ser Leu Leu Ser Arg Met Gln Asn Pro Leu 35 40 45 Arg His Phe Ser Ala Ser Ser Asp Tyr Asn Ser Tyr Glu Asp Gln Gly 50 55 60 Tyr Val Leu Asp Glu Asp Gln Asp Tyr Ala Leu Glu Glu Asp Val Pro 65 70 75 80 Leu Phe Leu Asp Glu Asp Val Pro Leu Leu Pro Ser Val Lys Leu Pro 85 90 95 Ile Val Glu Lys Leu Pro Arg Ser Ile Thr Trp Val Phe Thr Lys Arg 100 105 110 His Val Cys Phe Leu Phe Arg Thr Ser Phe Lys Ile Leu Ile Ile Tyr 115 120 125 Tyr Ile Val Ile Thr His Ser Ala Tyr Ile His Phe Phe Asn Ile Ala 130 135 140 Val Ala Ser 145 6 amino acids amino acid linear peptide 152 Trp Leu Lys Val Ile Leu 1 5 8 amino acids amino acid linear peptide 153 Leu Val Arg Asp Lys Ser Ile Ile 1 5 4 amino acids amino acid linear peptide 154 Met Val Arg His 1 26 amino acids amino acid linear peptide 155 Ala Val Lys Lys Met Arg Lys Met Lys Lys Lys Met Arg Lys Lys Ser 1 5 10 15 Arg Lys Lys Asn Ala Asn Phe Leu Lys Met 20 25 5 amino acids amino acid linear peptide 156 Thr Asp Leu Tyr Gly 1 5 7 amino acids amino acid linear peptide 157 Phe Leu His Tyr Ile Cys Ser 1 5 25 amino acids amino acid linear peptide 158 Leu Leu Ile Cys Ser Pro Tyr Leu Ile Asn Cys Ser Arg Asn Phe Gln 1 5 10 15 Asp Gly Trp Ala Gly Leu Trp Phe Gly 20 25 32 amino acids amino acid linear peptide 159 Ser Gly Arg Ala Ala Cys Ser Arg Gln Val Pro Arg Ser Gly Cys Phe 1 5 10 15 Gly His Ile Gly Asn Asn Ile Arg Ile Lys Thr Ser Tyr Val Asp Gln 20 25 30 12 amino acids amino acid linear peptide 160 Leu Ser Cys Leu Phe Asn Phe Cys Cys Phe Ser Ser 1 5 10 10 amino acids amino acid linear peptide 161 Ile Phe Lys Ser Asn Val Gly Lys Ile Gln 1 5 10 4 amino acids amino acid linear peptide 162 Trp Asn Cys Trp 1 14 amino acids amino acid linear peptide 163 Phe Asp Ile Gln Asp Asn Asn Tyr Cys Phe Pro Gly Phe Cys 1 5 10 59 amino acids amino acid linear peptide 164 Thr Ser Leu Pro Ser Leu His Gly Asn Phe Glu Ser Phe Phe Phe Asn 1 5 10 15 Leu Ala Thr Lys Lys Gly Asp Asp His Thr Cys Phe Tyr Phe Ile Leu 20 25 30 Ser Phe Val Leu Gln Ile Phe Asp Cys His Met His Glu Lys Tyr Glu 35 40 45 Pro Glu Ser Arg Ser Val Ser Ile Lys Phe Ile 50 55 15 amino acids amino acid linear peptide 165 Ile Ile Leu Leu Val Ser Gln Pro Leu Tyr Ile Arg Leu Ser Asp 1 5 10 15 56 amino acids amino acid linear peptide 166 Ile Ala Leu Ala Cys Gln Ser Glu Asp Lys Ser Ser Leu Phe Glu Asp 1 5 10 15 Glu Asp Arg Gln Pro Cys Ser Glu His Cys Tyr Leu Lys Val Ser Ile 20 25 30 Ser Leu Pro Leu Ser Leu Asn Phe Phe Val Tyr Ser Leu Ile Thr Phe 35 40 45 Ile Ser Tyr Trp Phe Asn Ile Lys 50 55 50 amino acids amino acid linear peptide 167 Val Arg Ser Val Thr Glu Ala Asp His Val Met Asp Asn Asp Asn Ser 1 5 10 15 Ile Ser Asn Lys Ile Val Val Ser Asp Pro Asn Asn Thr Met Trp Thr 20 25 30 Pro Val Glu Lys Asp Leu Tyr Leu Lys Gly Ile Glu Ile Phe Gly Arg 35 40 45 Asn Arg 50 68 amino acids amino acid linear peptide 168 Lys Asn Lys Asn Arg Phe Asn Ala Leu Ile Tyr Ile Leu Thr Leu Tyr 1 5 10 15 Ser Leu Ile Met Leu Val Arg Ser Cys Asp Val Ala Leu Asn Ile Leu 20 25 30 Arg Gly Leu Lys Thr Cys Leu Glu Ile Tyr Asn Tyr Met Arg Glu Gln 35 40 45 Asp Gln Cys Thr Met Ser Leu Asp Leu Asn Lys Thr Thr Gln Arg His 50 55 60 Asn Gln Val His 65 23 amino acids amino acid linear peptide 169 Lys His Met Lys Phe Pro Ile Cys Val Asp Gly Phe Ile Thr Gly Tyr 1 5 10 15 Gln Lys Ser Ile Ser Lys Lys 20 22 amino acids amino acid linear peptide 170 Val Gly Pro Gln Lys Ile Glu Thr Pro Lys Ile Cys Ser Leu Ser Ala 1 5 10 15 Cys Phe Lys Glu Asn Asn 20 41 amino acids amino acid linear peptide 171 Ala Leu His Thr Met His Leu Gln Val Lys Met Trp Thr Ala Met Pro 1 5 10 15 Leu Phe Asn Ser Arg Lys Leu Leu Arg Glu Ile Leu Arg Val Cys His 20 25 30 Ser Ile Phe Pro Lys Pro Glu Asp Pro 35 40 108 amino acids amino acid linear peptide 172 Val Cys Ile Phe Cys Ser Gly Ala Gln Arg Ile Ala Thr Ile Ala Leu 1 5 10 15 Glu Asp Val Ile Val Gln Leu Ala Asn Ala Gln Ile Asp Asn Val Leu 20 25 30 Val Leu Leu Leu Ile Val Asn Ala Ile Gln Ile Phe Val Gly Val Val 35 40 45 Leu Leu Gly Asn Thr Phe Thr Ser Ile Ser Leu Tyr Thr Asn Ser Ile 50 55 60 Ile Lys Val Ile Gln Thr Lys Ser Leu Ile Lys Lys Thr Leu Tyr Ile 65 70 75 80 Ala Val Glu Met Ala Leu Leu Val Arg His Gln Cys Lys Ser Asn Ala 85 90 95 Arg Thr Cys Asn Ser Ser Phe Lys Pro Ile Lys Arg 100 105 17 amino acids amino acid linear peptide 173 Ser Thr Ser Asn Pro Tyr Arg Lys Phe Lys Thr Asn Tyr Thr Lys Asp 1 5 10 15 Ile 7 amino acids amino acid linear peptide 174 Leu Ser Phe Pro Val Phe Tyr 1 5 39 amino acids amino acid linear peptide 175 Ile Leu Ile Gly Lys Ser Asp Val His Gly Trp Gly Ala Phe Thr Trp 1 5 10 15 Val Ser Asn His Val Asn Ile Arg Ile Ser Leu Ile Val Ile Gly Ala 20 25 30 Phe Ile Thr Leu Phe Phe Phe 35 4 amino acids amino acid linear peptide 176 Cys Phe Ile Leu 1 6 amino acids amino acid linear peptide 177 Thr Ile Lys Tyr Ile Val 1 5 53 amino acids amino acid linear peptide 178 Tyr Gly Leu Thr Arg Gln Asp Ser Leu Lys Lys Asn Glu Tyr Leu Gly 1 5 10 15 Glu Tyr Thr Gly Glu Leu Ile Thr His Asp Glu Ala Asn Glu Arg Gly 20 25 30 Arg Ile Glu Asp Arg Ile Gly Ser Ser Tyr Leu Phe Thr Leu Asn Asp 35 40 45 Gln Val Thr Ser Glu 50 28 amino acids amino acid linear peptide 179 Ser Asn Val Leu Ile Ile Arg Gly Leu His Ile Tyr Ser Asn Gln Ser 1 5 10 15 Asn Ile Tyr Phe Thr Ala Arg Asn Arg Cys Ser Pro 20 25 13 amino acids amino acid linear peptide 180 Arg Lys Arg Val Gln Ile Ser Gln Ser Leu Ser Lys Thr 1 5 10 16 amino acids amino acid linear peptide 181 Leu Leu Arg Gln Gly Thr Lys Pro Leu Tyr Phe Ile Leu Asn Lys Tyr 1 5 10 15 13 amino acids amino acid linear peptide 182 His Tyr Thr Asn Lys Asn Thr Tyr Val Ser Phe Phe Ser 1 5 10 24 amino acids amino acid linear peptide 183 Ile Val Tyr Gln Leu Tyr Ser Ser Leu Ile Gly Phe His Ile Glu Asp 1 5 10 15 Ile Pro Arg Asn Ser Asn Ser Phe 20 78 amino acids amino acid linear peptide 184 Met Ile Phe Ser Cys Arg Glu Asn Leu Gly Tyr Glu Asn Leu Trp Phe 1 5 10 15 Arg Val Gln Leu Met Ile Val Arg Gly Asp Gln Arg Ile Gly Leu Phe 20 25 30 Ala Glu Arg Ala Ile Glu Glu Gly Glu Glu Leu Phe Phe Asp Tyr Cys 35 40 45 Tyr Gly Pro Glu His Ala Asp Trp Ser Arg Gly Arg Glu Pro Arg Lys 50 55 60 Thr Gly Ala Ser Lys Arg Ser Lys Glu Ala Arg Pro Ala Arg 65 70 75 37 amino acids amino acid linear peptide 185 Gly Glu Ala Ala Ile Gln Ala Val Leu Phe Leu Cys Tyr Gly Ile Ser 1 5 10 15 Ile Asn Asn Val Met Leu Phe Cys Val Thr Lys Pro Lys Leu Lys Phe 20 25 30 Leu Phe Tyr Leu Phe 35 9 amino acids amino acid linear peptide 186 Gly Val Leu Phe Val Ser Tyr Val Ser 1 5 10 amino acids amino acid linear peptide 187 Leu Ser Lys Phe Ser Phe Cys Ile Ser Ile 1 5 10 6 amino acids amino acid linear peptide 188 Lys Gln Cys Leu Cys Cys 1 5 29 amino acids amino acid linear peptide 189 Thr Phe Gly Lys Lys Lys Leu Cys Thr Thr Leu His Leu Phe Ser Leu 1 5 10 15 His Leu Ala Lys Asn His Ile Thr Gln Val Cys Gly Thr 20 25 6 amino acids amino acid linear peptide 190 Cys Thr Lys Met Ser Lys 1 5 12 amino acids amino acid linear peptide 191 Trp Val Leu Ser Leu Lys Lys Asn Ile Gly Tyr Glu 1 5 10 19 amino acids amino acid linear peptide 192 Ser Ile Val Arg Ile Leu Gly Ile Ser Ser Phe Gly Phe Lys Thr Phe 1 5 10 15 Phe Glu Ile 24 amino acids amino acid linear peptide 193 Phe Cys Ser Leu Leu Ser Asn Thr Trp Lys Asn His Gln Gln Ser Gly 1 5 10 15 Cys Ser Leu Arg Lys Val Leu Leu 20 10 amino acids amino acid linear peptide 194 Cys Lys Tyr Val Phe Asp Ala Ser Asn Ile 1 5 10 4 amino acids amino acid linear peptide 195 Tyr Leu Asn Lys 1 13 amino acids amino acid linear peptide 196 Lys Gln Lys Lys Arg Lys Lys Leu Phe Lys Ile Arg Lys 1 5 10 24 amino acids amino acid linear peptide 197 Leu Phe Ser Lys Asn Leu Asn Tyr Lys Leu Lys Cys Leu Glu Ser Arg 1 5 10 15 Thr Thr Ile Ala Lys Tyr Lys Cys 20 5 amino acids amino acid linear peptide 198 Ile Tyr Met Lys Met 1 5 13 amino acids amino acid linear peptide 199 Lys Thr Cys Trp Ile Cys Gly Ile Val Asn Asp His Gly 1 5 10 4 amino acids amino acid linear peptide 200 Met Ala Gly Ser 1 4 amino acids amino acid linear peptide 201 Ile His Tyr Phe 1 48 amino acids amino acid linear peptide 202 Lys Ser Asn Phe Phe Ile Ser Ile Ile Cys Phe Lys Glu Lys Lys Asn 1 5 10 15 Thr Arg Arg Leu Ser Ile Cys Arg Leu Cys Ser Ser Val Asn Leu Tyr 20 25 30 Phe Lys Thr Gly Gly Leu Phe Ile Thr Ile Ser Leu Asp Met Phe Leu 35 40 45 24 amino acids amino acid linear peptide 203 Cys Arg Pro Lys Asn Arg Glu Ile Arg Lys Gly Thr Phe Val Val Ile 1 5 10 15 Val Thr Lys Gln Lys Ser Leu Tyr 20 11 amino acids amino acid linear peptide 204 Ile Ile Arg Lys Asp Glu Lys Ile Lys Pro Leu 1 5 10 12 amino acids amino acid linear peptide 205 Leu Asp Asp His Arg Arg Gly Cys Gln Leu Gln Ser 1 5 10 34 amino acids amino acid linear peptide 206 Cys Phe Tyr Ile Asp Leu Ser Tyr Ile Leu Cys Ser Phe Thr Phe Lys 1 5 10 15 Lys Gln Tyr His Pro Ile Phe Phe Leu Leu Leu Ser Val Ser Ile Phe 20 25 30 Ala Asn 21 amino acids amino acid linear peptide 207 Arg Asn Thr Lys Glu His Lys Lys Gln Leu Val Pro Asp Ser Thr Ile 1 5 10 15 Ser Asn Asp Leu His 20 106 amino acids amino acid linear peptide 208 Pro Pro Pro Pro Ser Ile Phe Pro Leu Ser Phe Thr Ser Leu Ser Leu 1 5 10 15 Tyr Leu Leu Asn Ser Gly His Arg Leu Arg Arg Phe Leu Cys Tyr Ser 20 25 30 Pro Gly Arg Cys Arg Ser Leu Ile His Asp Leu Val Ser His His Arg 35 40 45 Leu His Phe Asn Pro Gln Ser Leu Arg Lys Thr Arg Met Leu Cys Ser 50 55 60 Pro Phe Pro Ser Leu His Leu Leu Asp Arg Ser Leu His Arg Pro Ser 65 70 75 80 Leu Cys Leu Trp Asp Gln Lys Asn His Glu His Asp His Val Tyr Lys 85 90 95 Ser Arg Gln Lys Leu Val Ser Cys Asp Thr 100 105 5 amino acids amino acid linear peptide 209 Lys Met Asp Val Gly 1 5 15 amino acids amino acid linear peptide 210 Gly Phe Val Leu Phe Gly Ala Thr Arg Ser Asp Ala Asp Val Val 1 5 10 15 32 amino acids amino acid linear peptide 211 Gln His Tyr Ile Trp Gly Leu Arg Gly Gly Glu Val Val Arg Glu Ser 1 5 10 15 Arg Cys Gly Ser Asp Leu Trp Tyr Asn Val Val Val Glu Ala Lys Arg 20 25 30 11 amino acids amino acid linear peptide 212 Gly Arg Lys Ser Cys Gly Gly Gly Tyr Gly Gly 1 5 10 42 amino acids amino acid linear peptide 213 Pro Pro His Ser Phe Gly Gly Ser Gln Phe Cys Glu Leu Val Tyr Val 1 5 10 15 Leu His Leu Cys Trp Asn Trp Phe Asn Glu Asp Leu Gln Arg Val Phe 20 25 30 Gly Phe Cys Glu Tyr Val Asp Phe Glu His 35 40 6 amino acids amino acid linear peptide 214 Glu Val Glu Lys Arg Leu 1 5 4 amino acids amino acid linear peptide 215 Ile Met Cys Phe 1 27 amino acids amino acid linear peptide 216 Ser Cys Val Arg Tyr Leu Thr Tyr Tyr Thr His Leu Leu Asn Val Phe 1 5 10 15 Glu Ile Phe Leu Phe Leu Phe Ser Ile Ser Cys 20 25 25 amino acids amino acid linear peptide 217 Glu Phe Asn Pro Tyr Ile Cys His Lys Asn Ser Arg Ile Ser Glu Ser 1 5 10 15 Lys Asn Ile Leu Ser Lys Asn Asn His 20 25 16 amino acids amino acid linear peptide 218 Leu Tyr Phe Tyr Asn Thr Pro Phe Leu Arg Lys Thr Trp Arg Phe Asn 1 5 10 15 12 amino acids amino acid linear peptide 219 Lys Ile Ser Asp Leu Arg Arg Ser Phe Lys Cys Val 1 5 10 6 amino acids amino acid linear peptide 220 Leu Asn Leu Arg Ile Glu 1 5 25 amino acids amino acid linear peptide 221 Tyr Ser His Ile Tyr Ile Phe Glu Asp Leu Asn Ser Phe Cys Phe Phe 1 5 10 15 His Ile Cys Ile Ile Tyr Lys Leu Lys 20 25 9 amino acids amino acid linear peptide 222 Ile Leu Ile Tyr Ile Met Thr Leu Ile 1 5 10 amino acids amino acid linear peptide 223 Val Leu Pro Asp Thr Pro Lys Cys Ile Tyr 1 5 10 9 amino acids amino acid linear peptide 224 Ser Ile Asn Ile Phe Ser Leu Val Tyr 1 5 14 amino acids amino acid linear peptide 225 Thr Lys Leu Ser His Lys Tyr Glu Leu Thr Pro Phe Phe Leu 1 5 10 13 amino acids amino acid linear peptide 226 Ala Val Lys Arg Gln Ala Asn Pro Thr Ser Thr Tyr Ile 1 5 10 30 amino acids amino acid linear peptide 227 Tyr Tyr Ile Leu Lys Ile Lys Ile Phe Leu Asn Phe Pro Tyr Tyr Phe 1 5 10 15 Pro Phe Lys Ala Ser Lys Ser Lys Tyr Val Ser Ser Arg Leu 20 25 30 15 amino acids amino acid linear peptide 228 Phe Ser Leu Ile Arg Phe Ser Thr Lys Lys Asn Gln Leu Leu Ile 1 5 10 15 39 amino acids amino acid linear peptide 229 Lys Thr Leu Cys Ile Ile Leu Phe Thr Asn Ile Arg Glu Asp Glu Lys 1 5 10 15 Lys Arg Arg Gly Glu Trp Leu Met Glu Lys Val Ser Phe Thr Pro Asn 20 25 30 Ile Tyr Glu Leu Thr Arg Leu 35 9 amino acids amino acid linear peptide 230 Asn Pro Tyr Ile Leu Ile Val Cys Leu 1 5 4 amino acids amino acid linear peptide 231 Ile Asn Asn Ile 1 19 amino acids amino acid linear peptide 232 Ser Ile Met Leu Phe Val Pro Cys Met Ile His Lys Thr Phe Ile Phe 1 5 10 15 Glu Phe Val 37 amino acids amino acid linear peptide 233 Glu Asn His Glu Asp Asp Gly Glu Gly Leu Pro Pro Glu Leu Asn Gln 1 5 10 15 Ile Lys Glu Gln Ile Glu Lys Glu Arg Phe Leu His Ile Lys Val Arg 20 25 30 Asp Ile Trp Leu Leu 35 9 amino acids amino acid linear peptide 234 Tyr Phe Ile Leu Phe Cys Met Phe Phe 1 5 10 amino acids amino acid linear peptide 235 Lys Leu Arg Arg Gly Glu Asp Leu Ile Ser 1 5 10 11 amino acids amino acid linear peptide 236 Leu Tyr Asp Ser Lys Glu Met Leu Arg Tyr Ile 1 5 10 4 amino acids amino acid linear peptide 237 Thr Val Ile His 1 13 amino acids amino acid linear peptide 238 Ser Leu Lys Leu Lys Arg Glu Ile Ser Lys Leu Leu Asn 1 5 10 26 amino acids amino acid linear peptide 239 Lys Gln Asn Leu Glu Asn Ala Ser Glu Ser Ile Thr Thr Ser Arg Ser 1 5 10 15 Val Gly Tyr Pro Lys Leu Arg Ile Lys Lys 20 25 4 amino acids amino acid linear peptide 240 Leu Ile Tyr Leu 1 5 amino acids amino acid linear peptide 241 Tyr Lys Ala Gly Thr 1 5 29 amino acids amino acid linear peptide 242 Ile Phe Leu Phe Leu Ser Asn Lys Ile Val Ile Gln Phe Val Phe Phe 1 5 10 15 Ser Thr Lys Lys Leu Asn Arg Ser Lys Leu Phe Phe Phe 20 25 34 amino acids amino acid linear peptide 243 His Ser Ala Lys Lys Ala Lys Ile Asp Ala Tyr Ile Lys Lys Ser Lys 1 5 10 15 Ser Lys Leu Leu Tyr Ser Ser Ile Leu Val Ser Leu Tyr Ile Glu Ser 20 25 30 Ser Phe 18 amino acids amino acid linear peptide 244 Asn Leu Lys Asn His Leu Pro Ile Tyr Tyr Leu Ile Asn Arg Glu Asn 1 5 10 15 Ser Ser 17 amino acids amino acid linear peptide 245 Asp Thr Phe Gln Val Trp Leu Leu Met Leu His Thr Ile Asn Arg Leu 1 5 10 15 Thr 100 amino acids amino acid linear peptide 246 Thr Ser Pro Leu Gln Arg Met Ile Met Glu Glu Thr Thr Asn His Phe 1 5 10 15 Cys Arg Glu Cys Lys Thr His Phe Val Ile Ser Val Pro His Leu Ile 20 25 30 Ile Ile Leu Thr Lys Ile Lys Val Met Phe Leu Met Arg Ile Lys Ile 35 40 45 Met Leu Leu Lys Lys Met Tyr His Tyr Phe Leu Met Lys Met Tyr His 50 55 60 Tyr Tyr Gln Val Ser Ser Phe Gln Leu Leu Arg Ser Tyr His Asp Pro 65 70 75 80 Leu His Gly Ser Ser Pro Lys Gly Met Cys Val Phe Cys Phe Val Leu 85 90 95 Val Ser Lys Tyr 100 4 amino acids amino acid linear peptide 247 Ser Tyr Thr Ile 1 13 amino acids amino acid linear peptide 248 Ser Leu Ile Val His Ile Tyr Ile Ser Leu Thr Leu Gln 1 5 10 4 amino acids amino acid linear peptide 249 Pro Ala Asp Gly 1 4 amino acids amino acid linear peptide 250 Phe Cys Asp Trp 1 8 amino acids amino acid linear peptide 251 Glu Thr Asn Leu Leu Phe Glu Trp 1 5 6 amino acids amino acid linear peptide 252 Gly Thr Arg Ile Glu Gln 1 5 11 amino acids amino acid linear peptide 253 Gly Arg Asn Gln Glu Arg Lys Met Arg Ile Phe 1 5 10 18 amino acids amino acid linear peptide 254 Arg Cys Arg Pro Ile Tyr Met Val Ser Phe Cys Ile Thr Tyr Val Leu 1 5 10 15 Asp Tyr 5 amino acids amino acid linear peptide 255 Phe Val Val His Ile 1 5 41 amino acids amino acid linear peptide 256 Thr Ala Gln Glu Ile Phe Arg Thr Val Gly Gln Asp Tyr Gly Leu Asp 1 5 10 15 Asp Leu Val Val Arg Arg Ala Leu Ala Lys Tyr Leu Glu Val Asp Val 20 25 30 Ser Asp Ile Leu Val Thr Ile Phe Glu 35 40 30 amino acids amino acid linear peptide 257 Lys Leu His Thr Ser Ile Asn Asn Phe Pro Ala Tyr Leu Ile Phe Val 1 5 10 15 Val Phe Arg Arg Glu Lys Cys Phe Lys Phe Ser Asn Leu Met 20 25 30 51 amino acids amino acid linear peptide 258 Glu Arg Tyr Asn Glu Leu Lys Leu Lys Asn Asp Gly Thr Ala Gly Glu 1 5 10 15 Ala Ser Asp Leu Thr Ser Lys Thr Ile Thr Thr Ala Phe Gln Asp Phe 20 25 30 Ala Asp Arg Arg His Cys Arg Arg Cys Met Val Thr Leu Asn Leu Ser 35 40 45 Phe Leu Ile 50 36 amino acids amino acid linear peptide 259 Pro Gln Lys Arg Glu Met Ile Ile His Val Phe Ile Leu Phe Tyr His 1 5 10 15 Leu Phe Tyr Arg Tyr Ser Ile Val Ile Cys Met Arg Ser Met Ser Pro 20 25 30 Ser Leu Asp Pro 35 9 amino acids amino acid linear peptide 260 Ala Leu Asn Ser Phe Lys Leu Phe Cys 1 5 6 amino acids amino acid linear peptide 261 Phe His Asn Pro Tyr Ile 1 5 50 amino acids amino acid linear peptide 262 Val Ile Asn Leu Ile Arg Leu Leu Trp Leu Val Arg Ala Lys Thr Asn 1 5 10 15 Leu Val Cys Leu Arg Met Lys Ile Asp Asn His Ala Val Ser Ile Val 20 25 30 Thr Ser Arg Ser Leu Ser Leu Ser Leu Ser Leu Ser Ile Phe Leu Ser 35 40 45 Ile Pro 50 12 amino acids amino acid linear peptide 263 Leu Arg Leu Leu Val Thr Gly Leu Ile Leu Asn Arg 1 5 10 5 amino acids amino acid linear peptide 264 Gln Lys Leu Ile Met 1 5 23 amino acids amino acid linear peptide 265 Trp Ile Met Ile Thr Leu Tyr Gln Thr Arg Leu Trp Ser Gln Ile Gln 1 5 10 15 Thr Thr Leu Cys Gly Arg Leu 20 5 amino acids amino acid linear peptide 266 Arg Arg Ile Phe Thr 1 5 19 amino acids amino acid linear peptide 267 Lys Glu Leu Arg Tyr Leu Gly Glu Thr Gly Lys Lys Ile Lys Ile Asp 1 5 10 15 Leu Met His 8 amino acids amino acid linear peptide 268 Tyr Ile Tyr Leu His Cys Ile Pro 1 5 10 amino acids amino acid linear peptide 269 Leu Cys Trp Phe Ala Val Val Met Leu His 1 5 10 9 amino acids amino acid linear peptide 270 Thr Tyr Phe Gly Gly Leu Arg Arg Ala 1 5 15 amino acids amino acid linear peptide 271 Arg Phe Thr Ile Thr Cys Ala Asn Lys Ile Asn Val Leu Cys His 1 5 10 15 28 amino acids amino acid linear peptide 272 Thr Leu Thr Lys Leu His Lys Asp Thr Ile Arg Tyr Thr Asn Leu Cys 1 5 10 15 Arg Asn Tyr Ser His Asp Met Tyr Val Lys Asn Thr 20 25 95 amino acids amino acid linear peptide 273 Ser Phe Leu Tyr Val Leu Met Val Leu Ser Gln Val Thr Lys Lys Val 1 5 10 15 Ser Arg Lys Ser Ser Arg Ser Val Arg Lys Lys Ser Arg Leu Arg Lys 20 25 30 Tyr Ala Arg Tyr Pro Pro Ala Leu Lys Lys Thr Thr Ser Gly Glu Ala 35 40 45 Lys Phe Tyr Lys His Tyr Thr Pro Cys Thr Cys Lys Ser Lys Cys Gly 50 55 60 Gln Gln Cys Pro Cys Leu Thr His Glu Asn Cys Cys Glu Lys Tyr Cys 65 70 75 80 Gly Tyr Val Ile Gln Phe Phe Leu Ser Arg Lys Ile His Glu Ile 85 90 95 22 amino acids amino acid linear peptide 274 Phe Glu His Glu Phe Val Phe Phe Val Gln Val Leu Lys Gly Leu Gln 1 5 10 15 Gln Ser Leu Trp Arg Met 20 16 amino acids amino acid linear peptide 275 Leu Cys Asn Trp Pro Met His Lys Ser Thr Met Ser Leu Phe Cys Cys 1 5 10 15 11 amino acids amino acid linear peptide 276 Met Arg Ser Arg Ser Leu Ser Glu Leu Ser Ser 1 5 10 13 amino acids amino acid linear peptide 277 Val Thr Leu Ser Leu Gln Tyr Leu Phe Ile Gln Ile Leu 1 5 10 6 amino acids amino acid linear peptide 278 Phe Lys Pro Lys Val Leu 1 5 5 amino acids amino acid linear peptide 279 Lys Lys Leu Tyr Ile 1 5 7 amino acids amino acid linear peptide 280 Leu Trp Arg Trp His Ser Trp 1 5 17 amino acids amino acid linear peptide 281 Asp Thr Ser Ala Asn Pro Met Gln Glu His Ala Ile Pro Pro Ser Asn 1 5 10 15 Gln 45 amino acids amino acid linear peptide 282 Lys Gly Asn Gln Arg Gln Ile Arg Thr Glu Asn Leu Lys Leu Ile Ile 1 5 10 15 Arg Lys Thr Phe Asn Tyr His Phe Pro Tyr Phe Thr Arg Phe Ser Leu 20 25 30 Glu Ser Leu Met Phe Met Asp Gly Val His Leu His Gly 35 40 45 5 amino acids amino acid linear peptide 283 Leu Leu Val His Ser 1 5 21 amino acids amino acid linear peptide 284 His Phe Phe Phe Phe Asn Asn Val Leu Tyr Phe Arg Pro Leu Asn Ile 1 5 10 15 Leu Cys Asp Met Val 20 18 amino acids amino acid linear peptide 285 Pro Val Arg Thr Leu Leu Lys Arg Met Ser Ile Ser Glu Asn Ile Leu 1 5 10 15 Glu Asn 11 amino acids amino acid linear peptide 286 Ser Leu Met Met Lys Leu Met Ser Val Gly Glu 1 5 10 11 amino acids amino acid linear peptide 287 Lys Ile Gly Leu Val Leu Pro Thr Ser Leu Pro 1 5 10 9 amino acids amino acid linear peptide 288 Leu Gln Asn Asn Phe Glu Val Thr Phe 1 5 51 amino acids amino acid linear peptide 289 Ser Phe Ala Gly Tyr Thr Ser Ile Arg Ile Lys Val Thr Phe Ile Leu 1 5 10 15 Gln Leu Glu Ile Asp Ala Arg Arg Lys Gly Asn Glu Phe Lys Phe Leu 20 25 30 Asn His Ser Ala Arg Pro Asn Cys Tyr Ala Lys Val Leu Ser Arg Tyr 35 40 45 Thr Leu Ser 50 26 amino acids amino acid linear peptide 290 Thr Asn Thr Asn Ile Ile Gln Thr Lys Ile Leu Met Leu Val Ser Leu 1 5 10 15 Val Lys Ser Cys Ile Asn Phe Thr Arg Arg 20 25 16 amino acids amino acid linear peptide 291 Leu Val Phe Ile Leu Lys Ile Phe Gln Glu Thr Gln Thr His Phe Lys 1 5 10 15 7 amino acids amino acid linear peptide 292 Phe Phe Leu Val Glu Lys Ile 1 5 10 amino acids amino acid linear peptide 293 Val Thr Lys Ile Tyr Gly Phe Val Cys Ser 1 5 10 57 amino acids amino acid linear peptide 294 Glu Glu Ile Arg Gly Leu Val Tyr Leu Arg Arg Glu Gln Ser Lys Lys 1 5 10 15 Val Arg Ser Phe Ser Ser Thr Thr Ala Met Asp Gln Asn Met Arg Ile 20 25 30 Gly Arg Val Val Glu Asn Leu Glu Arg Leu Val Leu Leu Lys Gly Leu 35 40 45 Arg Lys Pro Val Gln Leu Val Ser Phe 50 55 21 amino acids amino acid linear peptide 295 Ser Glu Glu Lys Gln Gln Phe Lys Gln Ser Phe Phe Tyr Val Met Val 1 5 10 15 Tyr Gln Leu Ile Met 20 66 amino acids amino acid linear peptide 296 Cys Tyr Phe Val Leu Leu Asn Gln Asn Leu Ser Phe Cys Phe Ile Cys 1 5 10 15 Phe Arg Val Phe Cys Leu Tyr His Met Cys Leu Asn Phe Gln Ser Phe 20 25 30 Leu Phe Val Phe Gln Phe Lys Asn Asn Val Tyr Val Val Ser Leu His 35 40 45 Arg Pro Leu Glu Lys Lys Ser Phe Ala Gln Leu Tyr Ile Tyr Leu Val 50 55 60 Phe Ile 65 4 amino acids amino acid linear peptide 297 Arg Lys Ile Thr 1 18 amino acids amino acid linear peptide 298 His Lys Ser Val Val Arg Asn Val Gln Lys Cys Gln Asn Asn Gly Phe 1 5 10 15 Tyr His 9 amino acids amino acid linear peptide 299 Lys Lys Ile Leu Val Met Asn Glu Val 1 5 18 amino acids amino acid linear peptide 300 Val Leu Ala Arg Leu Val Leu Lys Arg Phe Ser Arg Phe Asn Phe Val 1 5 10 15 Val Tyr 32 amino acids amino acid linear peptide 301 Val Ile His Gly Arg Ile Ile Asn Lys Val Ala Val Ala Tyr Glu Arg 1 5 10 15 Phe Tyr Phe Asn Val Asn Met Tyr Leu Met His Leu Thr Phe Ser Ile 20 25 30 22 amino acids amino acid linear peptide 302 Thr Asn Lys Asn Lys Lys Lys Glu Lys Ser Ser Leu Lys Ser Glu Ser 1 5 10 15 Asn Tyr Phe Gln Lys Ile 20 21 amino acids amino acid linear peptide 303 Ile Ile Asn Leu Asn Val Trp Asn Arg Glu Arg Leu Leu Leu Asn Ile 1 5 10 15 Asn Ala Lys Tyr Thr 20 20 amino acids amino acid linear peptide 304 Arg Cys Glu Lys His Val Gly Phe Val Glu Ser Leu Met Thr Thr Val 1 5 10 15 Lys Trp Arg Asp 20 23 base pairs nucleic acid single linear DNA - 1..23 /note= “primer Nir Cla-73” 305 GGCGGACATC AAACCTACTT AGC 23 24 base pairs nucleic acid single linear DNA - 1..24 /note= “primer cer1n2” 306 TGTAACATTA AGGCCTTTCC TTTT 24 23 base pairs nucleic acid single linear DNA - 1..23 /note= “primer Nir-C-2-S-N” 307 CGGTCATCAA GTGAGTTATG AAG 23 19 base pairs nucleic acid single linear DNA - 1..19 /note= “primer cer1s659” 308 GGTCCAATCG GCAATGAGT 19 22 base pairs nucleic acid single linear DNA - 1..22 /note= “primer cer1ns10596n” 309 GTCCAATCGG CAATGAGTAG AG 22 22 base pairs nucleic acid single linear DNA - 1..22 /note= “primer Nir La-4Cla-S-S” 310 GTGTGCCTAA CAGTTTCCGC AC 22 24 base pairs nucleic acid single linear DNA - 1..24 /note= “primer cer1ns10265n” 311 TCTCGGAGAT GGTGCCATAT CAGC 24 40 base pairs nucleic acid single linear DNA - 1..40 /note= “primer fie3cds5′.seq” 312 ATGTCCTCTG GAGAGCAGAA GGAAGAGTCG TTTTACACGG 40 24 base pairs nucleic acid single linear DNA - 1..24 /note= “primer cer1ns10129n” 313 TCTGGAGAGC AGAAGGAAGA GTCG 24 22 base pairs nucleic acid single linear DNA - 1..22 /note= “primer cer1ns10030n” 314 CGAGTCATTG ACGTCAACAG TG 22 24 base pairs nucleic acid single linear DNA - 1..24 /note= “primer cer1ns9922n” 315 CTCGCAAATG TGCAGAGTCT TGTG 24 20 base pairs nucleic acid single linear DNA - 1..20 /note= “primer cer1n1570” 316 AGGTCATCGC TATGAAGTTC 20 20 base pairs nucleic acid single linear DNA - 1..20 /note= “primer cer1ns98f9511n” 317 GCTAGTTGTG GTATGGACAC 20 21 base pairs nucleic acid single linear DNA - 1..21 /note= “primer cer1ns98f9311s” 318 CACATGGACT GATGATCCAT C 21 20 base pairs nucleic acid single linear DNA - 1..20 /note= “primer cer1s2099” 319 GTAACCGTTG GTTTGGTGAT 20 25 base pairs nucleic acid single linear DNA - 1..25 /note= “primer Nir E-4-N-N” 320 GGTTAGTAAG TCAATGATGG TTAAG 25 19 base pairs nucleic acid single linear DNA - 1..19 /note= “primer cer1ns8795n” 321 GCGATAGGTA ATCAGAGAG 19 20 base pairs nucleic acid single linear DNA - 1..20 /note= “primer cer1ns8517n” 322 CTGTAATCAG GCAAACAGCC 20 20 base pairs nucleic acid single linear DNA - 1..20 /note= “primer cer1ns98f8483s” 323 CAGCCATGTC TGTCGATGGA 20 40 base pairs nucleic acid single linear DNA - 1..40 /note= “primer fie3cds3′.seq” 324 ATCCATCTTC TCTCTCACCA ATGCAGTGAA AATTTCTTAA 40 

What is claimed is:
 1. An isolated nucleic acid molecule comprising a FIE polynucleotide sequence, which polynucleotide sequence specifically hybridizes to SEQ ID NO: 1 or SEQ ID NO:3 under stringent conditions.
 2. The isolated nucleic acid molecule of claim 1, wherein the FIE polynucleotide is between about at least about 100 nucleotides in length.
 3. The isolated nucleic acid molecule of claim 1, wherein the FIE polynucleotide is SEQ ID NO:
 1. 4. The isolated nucleic acid molecule of claim 1, wherein the FIE polynucleotide is SEQ ID NO:3.
 5. The isolated nucleic acid molecule of claim 1, further comprising a plant promoter operably linked to the FIE polynucleotide.
 6. The isolated nucleic acid molecule of claim 5, wherein the plant promoter is from a FIE1 gene.
 7. The isolated nucleic acid of claim 6, wherein the FIE polynucleotide is linked to the promoter in an antisense orientation.
 8. An isolated nucleic acid molecule comprising a FIE polynucleotide sequence, which polynucleotide sequence encodes FIE polypeptide as shown in SEQ ID NO:2 or SEQ ID NO:4.
 9. a transgenic plant comprising an expression cassette containing a plant promoter operably linked to a heterologous FIE polynucleotide of claim
 1. 